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ABSTRACT   
 
Bioactive drugs are small molecules that can bind therapeutic targets like enzymes, 
proteins, and receptors and modulate their biological activities. Effective binding between 
bioactive drugs and receptors in vivo or in vitro is key to constructing useful tools in 
biomedical research and diagnosis. Molecular imprinting within surface/core cross-linked 
micelles was shown to afford water-soluble nanoparticle receptors for bioactive drugs. The 
molecularly imprinted nanoparticles obtained resembled proteins in size and were easy to 
prepare and very stable in adverse temperature or pH conditions. Strong imprinting effects 
were consistently observed for different bioactive molecules including alkaloids, folic acid, 
nonsteroidal anti-inflammatory drugs (NSAIDs), and catecholamines, in comparison to 
nonimprinted nanoparticles without the templates during the preparation. Fluorescent 





CHAPTER 1. GENERAL INTRODUCTION 
  
Dissertation Organization  
This dissertation consists of 6 chapters, focusing on investigations of molecularly 
imprinted nanoparticles (MINPs) for recognition and sensing of bioactive drug molecules. 
Chapter 1 is a review of molecular recognition, molecularly imprinted polymers (MIPs) and 
the latter’s applications as artificial receptors. Chapter 2 was published in the Journal of 
Organic Chemistry in 2019. In this manuscript, molecularly imprinting nanoparticle receptors 
were prepared for alkaloids with strong imprinting effects in comparison to nonimprinted 
nanoparticles prepared without the templates. The ionic nature of the cross-linkable surfactant 
was found to strongly affect the imprinting and recognition process. Chapter 3 was published 
in Bioconjugate Chemistry in 2018. In this manuscript, MINPs were prepared for folic acid 
and its derivatives. It was found that MINP could be used to reveal the relative contributions 
of different functional groups toward the binding, by comparing structural analogues during 
the binding processes. Chapter 4 was submitted for publication in 2019. In this manuscript, a 
thiourea-containing fluorescent functional monomer was employed to MINP sensors for 
NSAIDs including Indomethacin and Tolmetin. Micromolar binding affinities were obtained, 
with binding selectivity comparable to those by polyclonal antibodies. Chapter 5 was 
submitted for publication in 2019. A phenylboronic acid- and anthracene-containing 
fluorescent functional monomer was developed to construct MINP sensors for important 






Literature Reviews  
Molecular recognition is a fundamental step in biological processes such as enzymatic 
catalysis, protein crowding, molecular transport, cellular signaling, protein-protein association, 
and non-covalent binding of a ligand molecule by its receptor. All those biological processes 
involve the recognition of two or more molecular binding partners, leading either to their 
binding or to their dissociation.1 Numerous biological receptors are found in cells, with each 
receptor binding its intended target molecules. However, applications of biological receptors 
are limited by the high cost and delicate nature of proteins. Noncovalent interactions such as 
hydrogen bonding, electrostatic interactions, hydrophobic effect, π-π interactions are generally 
utilized in the study of molecular recognition.2 Because individual noncovalent interactions are 
normally weak, they are used together to obtain sufficient binding strength. Chemists have used 
these tools over the past several decades to create small organic molecules receptors, primarily 
in organic solvents.3-4 These synthetic receptors should have a highly complementary binding 
motif for the guest to achieve high affinity and selectivity. Many synthetic receptors have been 
developed for various applications, such as macrocycles,  whose concave structures have 
appropriate size and functionality for the guest molecule. Recently, foldamers with the benefit 
of using guest-triggered conformational changes to amplify the guest binding have been 
reported.5-11 In general, the synthetic receptors are prepared by step-by-step synthesize to 
construct the binding motif complementary to their guest molecules. As the complexity of the 
guest molecule increases, the design and synthesis will also become more and more 
challenging. 
Molecular imprinting technology has provided a very unique solution to the 




polymerization of cross-linker molecules and functional monomers around a template 
molecule. First, a complex is formed between the selected template molecule and a functional 
monomer via various covalent or noncovalent interactions, with the exact configuration of the 
complex different for different types of molecular imprinting techniques.23 A polymerization 
reaction is then carried out around the complex in the presence of cross-linking molecules, and 
the subsequent removal of some or all of the template molecules is required to provide 
recognition sites in the polymer network. The recognition sites usually have a three-
dimensional geometry complementary to the functional groups of the template molecule. In 
comparison to the synthesis of molecular receptors, molecular imprinting enables easy and 
convenient preparation of recognition sites for target molecules which are large or complex. 
This is partly the reason why molecularly imprinted polymer (MIPs) have been developed by 
researchers from various backgrounds for applications including separation, purification, 
enzyme-mimetic catalysis, and sensing.24-28 However, traditional MIP polymers face multiple 
challenges. Over the past decades, many different techniques have been used to improve the 
properties of traditional MIPs by developing different systems to improve the solubility, 
number of binding sites, and binding selectivity.27-42 Those systems include but are not limited 
to molecularly imprinting nanoparticles,43-49  micro/nanogels,37-42 and imprinting within 
dendrimers.27-28  
Bioactive drugs are normally small in size compared to their biological targets, but can 
modulate the activities of biological molecules like proteins, receptors, and enzymes by binding 
to them. For example, non-steroidal anti-inflammatory drugs, also known as NSAIDs, are one 
the most commonly prescribed pain-relieving drugs. These drugs relieve the pain by binding to 




prostaglandins and other prostanoids synthesis, such as thromboxanes.50 Vinblastine, a vinca 
alkaloid,  inhibits the assembly of microtubules by binding to tubulin, a protein that polymerizes 
into long chains or filaments that form microtubules.51 Thus, the development of artificial 
receptors toward these molecules is very significant, as it would provide useful tools in 
biomedical research and diagnosis. Various drug-binding systems have been reported. For 
example, different artificial folate receptors were developed in order to achieve highly selective 
binding toward folic acid.52-54 However, compared with natural receptors, most of those 
reported artificial receptors bind folic acid with very low affinities in aqueous solution,  not to 
mention those water-insoluble receptors.55-59 The main challenges come from the size and 
complexity of the drug molecule, the selective recognition among close relatives which differ 
subtly from the target drug molecule, and the reduced recognition effect in aqueous conditions. 
All these challenges encouraged us to develop synthetic receptors for bioactive drugs. 
In 2013, our research group reported a new molecular imprinting technique by forming 
molecularly imprinted nanoparticles (MINPs) with surface/core doubly cross-linking. After 
template removal, a hydrophobic pocket complementary to the template will be formed in the 
MINP. The MINP material is already used to develop receptors for bile salt derivatives, 
aromatic carboxylates, sulfonates, nonsteroidal anti-inflammatory drugs (NSAIDs), peptides 
and carbohydrates.43-48, 60 Besides, MINP is fully water-soluble and mimics enzymes in size. In 
this dissertation, we report MINP receptors for selective binding of different bioactive species, 
including alkaloids and folic acid. We also report MINP sensors for the selective binding and 
sensing of NSAIDs and catecholamine derivatives. 
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CHAPTER 2. ZWITTERIONIC MOLECULARLY IMPRINTED CROSS-LINKED 
MICELLES FOR ALKALOID RECOGNITION IN WATER 
  
Modified from a paper published in JOC, 2019, 84, 13457. 
Likun Duan1, Yan Zhao1*  
1Department of chemistry, Iowa State University, Ames, Iowa, 50011 United States  
* Corresponding Authors  
  
Abstract  
Molecular imprinting within surface/core doubly cross-linked micelles afforded water-soluble 
nanoparticle receptors for their template molecules. Extremely strong imprinting effects were 
consistently observed, with the imprinting factor >100:1 in comparison to nonimprinted 
nanoparticles prepared without the templates. The ionic nature of the cross-linkable surfactant 
strongly impacted the imprinting and binding process. Imprinted receptors prepared with a 
zwitterionic cross-linkable surfactant (4) outperformed a similar cationic one (1) when the 
template was zwitterionic or cationic, and preferred their templates over structural analogues 
regardless of their ionic characteristics. Electrostatic interactions, however, dominated the 
receptors made with the cationic surfactant. The same micellar imprinting applied to simple as 
well as complex alkaloids. Imprinted receptors from 4 were also shown to categorize their 





Molecular recognition is the basis of nearly every biological process including receptor–
ligand binding, enzymatic catalysis, and transport of molecules across membranes. In order for 
a supramolecular host to bind its guest strongly and selectively, the two must have a 
complementary interface where multiple noncovalent interactions engage. When the guest is 
small and symmetrical, a complementary host can be constructed relatively easily using an 
organic framework such as a macrocycle. When the guest becomes more complex in shape and 
functionality, as with most bioactive molecules, design and synthesis of a complementary host 
become much more challenging. The difficulty increases further with additional requirements 
such as preorganization of the host’s conformation for guest-binding, solubility in water, and 
ability to function under competitive aqueous environments. High specificity in binding also 
becomes a must for biomolecular recognition, since closely related biomolecules tend to have 
drastically different biological properties. 
All these demands make traditional stepwise total synthesis of supramolecular hosts 
impractical for biomolecular recognition. In this regard, molecular imprinting is an attractive 
alternative for building receptors for complex molecules.1,2 The method involves first formation 
of a template–functional monomer (FM) complex, either spontaneously through noncovalent 
interactions or chemically through reversible covalent bonds. The complex is then polymerized 
with a large amount of a cross-linker. Removal of the template from the resulting macroporous 
polymer network affords template-complementary binding sites in size, shape, and distribution 
of functional groups. Molecular imprinting can be applied readily to different-sized 
molecules1,2 and even large entities including viruses and bacteria.3-8 Its simplicity continues to 




Instead of using a macroporous polymeric network, our group found that micelles of doubly 
cross-linkable surfactant 1 could serve as an excellent platform for molecular imprinting 
(Scheme 1).21 The process involves a two-stage cross-linking, first on the surface of the micelle 
using diazide 2 via the click reaction and then in the micellar core using divinylbenzene (DVB) 
via free-radical polymerization. The cross-linked micelles are typically functionalized on the 
surface using monoazide 3 by another round of click reaction for increased hydrophilicity and 
facile purification. Micellar imprinting can be done directly in water, thanks to the ability of 
micelles to strengthen hydrogen bonds in their nonpolar core.22,23 The number of binding sites 
per cross-linked micelle is controlled by the surfactant/template ratio.21 The so-called 
molecularly imprinted nanoparticles (MINPs) are ~5 nm in diameter, and resemble proteins in 
their nanosize, hydrophilic exterior, and hydrophobic core. They mimic protein receptors in 
their binding of common biological guests such as peptides,24 carbohydrates,25 and can be 
converted into highly selective catalysts similar to enzymes.26 
The cross-linkable surfactant in micellar imprinting is the most important component for the 
synthesis. Not only does it set the boundary for imprinting by its self-assembled micelle, it also 
acts as the functional monomer and cross-linker to interact with the template through 
hydrophobic,21 electrostatic,21 and hydrogen-bonds.27 Cationic surfactant 1 was used in the 
majority of our micellar imprinting. Although it has allowed a wide range of biologically 
interesting molecules to be imprinted, its cationic nature may not always be desirable for 
biological applications. Because biological entities (proteins, nucleic acids, and lipids) vary in 
charge, we need to be able to tune the charge of our materials for specific applications. 
In this work, we designed and synthesized a new cross-linkable surfactant. Its zwitterionic 




imprinting and binding of charged template molecules. In comparison to our original 1, the new 
surfactant allowed MINPs to differentiate closely related natural products with varying ionic 
charges. It also enabled facile preparation of synthetic receptors for alkaloids, a highly 
important class of biomolecules with broad pharmaceutical applications.28,29   
 
 
Scheme 1. Preparation of MINP by surface–core double cross-linking of template-containing 




Results and Discussion 
Synthesis and Characterization of Zwitterionic Cross-Linkable Surfactant. 
Phosphatidylcholine is a major component of biological membranes.30,31 Its zwitterionic 
headgroup is connected via a glycerol to two fatty acid chains (Scheme 2). The headgroup is 
strongly solvated by water and provides a neutral background for a membrane to interact with 
its components including proteins and other lipids. It is known to cause low structural 
perturbation to associated water molecules. Related to this property, phosphatidylcholine-
containing amphiphilic polymers have strong abilities to resist biofouling, due to their low 
tendencies to trigger conformational changes of adsorbed proteins.32-35           
 
Scheme 2. Syntheses of cross-linkable surfactants 4. 
 
Synthesis of our phosphatidylcholine-like cross-linkable surfactant 4, 12-
(methacryloyloxy)dodecyl (2-(tri(prop-2-yn-1-yl)ammonio)ethyl) phosphate, is shown in 
Scheme 2. 1,12-Dodacanediol 5 is mono-methacrylated to afford 6. This step is the same as 
that in the synthesis of 1.21 The mono alcohol is then phosphorylated with ethylene glycol 
chlorophosphate 7, and the resulting cyclic phosphate is ring-opened by commercially available 




similar to 1 in many aspects—a C12 carbon chain, a tripropargylammonium group for surface 
cross-linking, and a methacrylate at the end of the hydrocarbon tail for core-cross-linking. The 
compound was fully characterized by 1H NMR spectroscopy, 13C NMR spectroscopy, and high-
resolution mass spectrometry.    
An extremely important property of a surfactant is its critical micelle concentration (CMC), 
above which micelles start to form spontaneously in water. There are many ways to determine 
the CMC of a surfactant.37 A method of choice utilizes an environmentally sensitive 
hydrophobic probe such as pyrene.38 The method requires very little amounts of materials and, 
in our hands, afforded similar CMC values as those determined from the reduction of surface 
tension for analogous surfactants.39 Typically, a series of surfactant solutions of varying 
concentrations are prepared using an aqueous solution containing 0.1 µM pyrene. The emission 
of pyrene has five vibronic bands, with the first band (I1) near 372 nm becoming stronger in a 
more polar environment and the third (I3) near 384 nm staying nearly constant. The I3/I1 ratio 
thus increases with decreasing environmental polarity. 
Figure 1 plots the I3/I1 ratio of pyrene against the concentration of 4 in Millipore water. The 
ratio stayed unchanged at low surfactant concentration, around 0.80. Apparently, the 
hydrophobic probe stayed in the aqueous phase under such conditions, even though the solution 
contained some surfactant molecules. As the concentration of 4 increased beyond a certain 
point, the I3/I1 ratio began to rise sharply, with almost a linear dependence on the surfactant’s 
concentration beyond the inflection point. The result was consistent with the formation of an 
increasing number of micelles at higher concentrations above the CMC, leading to a higher 
partition of the hydrophobic probe into the nonpolar region of the micelle. The inflection point 




number was lower than the 0.55 mM for the cationic surfactant 1.21 The result was reasonable, 
given the strong repulsion among the cationic headgroups in the micelle of 1 and the overall 
neutral charge of 4. 
 
Figure 1. Pyrene I3/I1 ratio as a function of [4].  [pyrene] = 0.1 μM. 
 
Binding Properties of Zwitterionic and Cationic MINPs. To understand how different 
headgroups impact micellar imprinting, we chose to study three model templates 8–10, all of 
biological origin. 3-Indolepropionic acid 8 is a natural product with potential therapeutic 
benefits for Alzheimer’s diease.40 Tryptophan 9 is a natural aromatic amino acid. Tryptamine 
10 is a monoamine alkaloid, able to bind human trace amine-associated receptors (hTAARs) in 
the central nervous system.41 The three compounds share the same hydrophobe (i.e., indole) 
but have different ionic characteristics. These features make them particularly suitable for 
probing relative contributions of hydrophobic and electrostatic interactions in the imprinting 














Preparation of the MINPs is reported in the Experimental Section. The surface- and core-
cross-linking of the micelle was monitored by 1H NMR spectroscopy. The surface-cross-linking 
chemistry had been confirmed independently by mass spectrometry after the surface-cross-
linkages were cleaved by periodate.42 Dynamic light scattering (DLS) allowed us to follow the 
change of size for the micelles during the surface-cross-linking, surface-functionalization, and 
core-cross-linking. The DLS size had been confirmed by transmission electron microscopy 
(TEM).43,44 Since a key different between surfactants 1 ad 4 was their ionic nature, we also 
determined the zeta potential of the corresponding MINPs. MINP1, i.e., MINP prepared with 1 
as the cross-linkable surfactant, afforded a zeta potential of 60.5 mV and MINP with 4 as the 
surfactant -14.4 mV (Figures S4 and S8). 
One benefit of using indole-derived compounds is that their binding could be studied 
conveniently by fluorescence titration. Figure 2a shows the emission spectra of 2.0 μM 8 in 50 
mM Tris buffer (pH = 7.4) upon the addition of 0–7.0 μM MINP4(8), i.e., MINP prepared with 
4 as the cross-linkable surfactant and 8 as the template. The higher concentration of the MINP 
caused a decrease of the main emission band at 363 nm. Two isoemissive points were observed 
at ca. 336 and 426 nm, suggesting a continuous transition from the free to the bound 8 during 
titration. A blank titration experiment showed that the MINP contributed negligibly to the 
observed fluorescence (Figure S18). The emission intensity at 363 nm fit nearly perfectly to a 
1:1 binding isotherm (Figure 2b). Nonlinear least squares fitting afforded a binding constant 
(Ka) of (6.56 ± 0.90) × 10




(i.e., NINP4), the binding was much weaker, with an estimated binding constant of 0.06 × 105 
M-1 (Figure S19). The imprinting factor (IF), thus, was >100:1, indicating an extremely strong 
imprinting effect.    
 
 
Figure 2. (a) Emission spectra of 8 (λex = 300 nm) upon the addition of different concentrations 
of MINP4(8) in 50 mM Tris buffer (pH = 7.4). [8] = 2.0 μM. The concentration of MINP was 
calculated based on a M.W. of 50,000 g/mol determined by DLS. (b) Nonlinear least squares 
fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm.  
Figure 3a,b shows the emission spectra of 8 titrated by MINP1(8) and the corresponding data 
fit to the 1:1 binding model, which yielded a Ka value of (13.2 ± 0.3) × 10
5 M-1. The guest 
continued to show weak binding toward nonimprinted nanoparticles (i.e., NINP1), with Ka ≈ 
0.09 × 105 M-1 (Figure S20). The imprinting factor (IF) hence was also  >100:1, indicating a 





Figure 3. (a) Emission spectra of 8 (λex = 300 nm) upon the addition of different concentrations 
of MINP1(8) in 50 mM Tris buffer (pH = 7.4). [8] = 2.0 μM. The concentration of MINP was 
calculated based on a M.W. of 50,000 g/mol determined by DLS. (b) Nonlinear least squares 
fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm.  
 
In addition to different binding constants, the emission spectra of the guest differed 
significantly in shape in the titrations with the two MINPs (Figures 2a and 3a). Whereas the 
cationic MINP1(8) caused a quenching effect of the broad emission band of the indole ring, 
multiple vibronic bands appeared for 8 in the presence of the zwitterionic MINP4(8). Indole 
derivatives have two over lapping electronic transitions, 1La and 
1Lb.
45-47 The 1La band is broad 
and sensitive to environmental polarity including hydrogen bonding interactions to the indole 
nitrogen and charged groups nearby.48 The 1Lb band, on the other hand, tends to have vibronic 
structures and meanwhile is less sensitive to the environment.49 The relative contribution of 1Lb 
band is known to increase in a hydrophobic microenvironment.50 Although the complexity of 
indole fluorescence and its sensitivity to multiple factors make it difficult to pinpoint the exact 




S21–36) suggests a common origin, most likely the stronger hydrophobicity of the zwitterionic 
micelle (vide infra).  
Given the complexity of the indole fluorescence, we also confirmed the bindings by 
isothermal titration calorimetry (ITC). This method measures the heat change during titration, 
and is able to afford a number of parameters including the binding enthalpy (∆H) and number 
of binding sites per nanoparticle (N), in addition to the binding constant. After background 
subtraction to account for the dilution effect, ITC showed that the number of binding sites per 
nanoparticle was 1.14 ± 0.13 for 8 by MINP4(8), consistent with the 1:1 binding suggested by 
the fluorescence titration (Figure 4). Because typical MINPs contain ~50 cross-linked 
surfactants per particle as estimated by DLS, the 1:1 binding was expected when a 50:1 
surfactant/template ratio was used in the preparation.21 The Ka value obtained was (6.78 ± 0.31) 
× 105 M-1, very similar to that from the fluorescence titration ((6.56 ± 0.90) × 105 M-1). For the 
binding of 8 by MINP1(8), ITC afforded a binding constant of (13.9 ± 0.5) × 10
5 M-1 (Figure 
S41), also in excellent agreement with what was obtained from the fluorescence titration. Since 
it was much quicker to perform fluorescence titration, we used this method whenever the 





Figure 4. ITC curve obtained at 298.15 K from titration of MINP4(8) with 8 in 50 mM Tris 
buffer (pH = 7.4). MINP4(8) = 10 µM in the cell. The concentration of 8 in the syringe was 
0.20 mM. 
 
Table 1 summarizes the binding constants obtained in this study. Since surfactant 1 was good 
to at imprinting anionic guests, we studied the binding of 8 first. In our hands, MINP1(8) bound 
the anionic template more strongly than MINP4(8) prepared with the same template (Table 1, 
entry 1). Although the result was fully expected from the favorable electrostatic interactions 
between the cationic micelle and anionic template, the 2-fold increase in binding represented a 
very modest effect. Our previous work showed that electrostatic interactions played important 










































roles in the MINP binding of anionic guests when 1 was the cross-linkable surfactant.21 It is 
Table 1. Binding constants and selectivity for MINPs imprinted against 8–10.a 
Entry Template Guest 
Ka (×10
5 M-1) CRRb 
MINP4 MINP1 MINP4 MINP1 
1 8 8  6.56 ± 0.90 
(6.78 ± 0.31) 
13.2 ± 0.3 
(13.9 ± 0.5) 
1 1 
2 8 9 3.84 ± 0.51 0.91 ± 0.31 0.59 0.07 
3 8 10 4.08 ± 0.47 0.43 ± 0.10 0.62 0.03 
4 9 8 2.95 ± 0.43 11.9 ± 3.7 0.38 13.4 
5 9 9 7.75 ± 0.87 0.89 ± 0.10 1 1 
6 9 10 3.38 ± 0.45 0.42 ± 0.02 0.44 0.47 
7 10 8 3.80 ± 0.43 9.84 ± 2.25 0.51 15.9 
8 10 9 3.77 ± 0.65 0.67 ± 0.13 0.50 1.08 
9 10 10 7.52 ± 0.72 0.62 ± 0.14 1 1 
10 none 8 0.06c  0.09c - - 
11 none 9 0.05c  0.04c - - 
12 none 10 0.05c  0.01c - - 
a The binding constants were obtained from fluorescence titrations performed in duplicates 
in 50 mM Tris buffer (pH = 7.4). The binding constants in parentheses were obtained from ITC. 
b CRR is the cross-reactivity ratio, defined as the binding constant of  a guest relative to that of 
the template for a particular MINP. c Binding was between the guest and nonimprinted 
nanoparticles (NINP4 or NINP1) prepared without any templates. The binding was very weak 




known that zwitterionic surfactants tend to pack more tightly than ionic ones during 
micellization due to reduced hydration of their headgroups.51 This suggest that the micelle of 4 
is more hydrophobic in the nonpolar interior than that of 1. The effect would strengthen the 
hydrophobic interactions between MINP4(8) and its template and most likely partly offset the 
loss of favorable electrostatic interactions between MINP1(8) and 8. 
When zwitterionic 9 was used as the template, MINP4(9) was able to bind the template with 
a Ka of 7.75 × 10
5 M-1 in Tris buffer (Table 1, entry 5). In contrast, MINP1(9) showed a much 
weaker binding for the same template, with a Ka of 0.89 × 10
5 M-1. The binding was nearly 9 
time weaker, corresponding to a 1.28 kcal/mol difference in binding free energy (∆∆G). One 
possible reason for the stronger ability of 4 to imprint 9 could be the zwitterionic nature of both 
compounds. Essentially, both the positively and negatively charged groups of the template 
could find suitable groups on the micelle to ion-pair during imprinting in case of 4, whereas 
only the negatively charged carboxylate of the template could enjoy favorable interactions with 
the surfactant if 1 is used to prepare MINP. Another possible reason is the  
“tighter and more hydrophobic micelle” of 4 mentioned above, which could help the imprinting 
and binding of any hydrophobic molecules. 
The benefit of the zwitterionic over cationic surfactant was also evident in the imprinting of 
the cationic template (10). Entry 9 of Table 1 shows that the binding constant for the template 
was 7.52 and 0.62 × 105 M-1 by MINP4(10) and MINP1(10), respectively. Since these numbers 
do not differ much from those for the zwitterionic template 9 (entry 5), the double ion-pairing 
reason mentioned above must be minor in micellar imprinting, otherwise eliminating the factor 




On the other hand, the “tighter and more hydrophobic micelle” of 4, would still help the 
imprinting and binding of any hydrophobic template, including the cationic 10.  
Another interesting observation was that the binding constants for 9 by MINP1(9) and 10 by 
MINP1(10) were quite similar, 0.89 and 0.62 × 105 M-1, respectively (entries 5 and 9). This 
might appear quite strange, as the cationic MINP should repel the cationic template (10) but at 
least be able to “tolerate” the zwitterionic one (9). The assumption for this prediction, however, 
was that 10 stayed protonated during binding. The pKa of a primary ammonium group is ~10. 
At pH 7.4 under our titration conditions, it should be largely protonated indeed, at least in 
solution. Nonetheless, a protonated amine can shift its pKa dramatically in different 
environments. When Isom et al. prepared 25 variants of staphylococcal nuclease with lysine 
residues at varying positions, for example, 19 of the (protonated) lysine residues have depressed 
pKa values, some as low as 5.3, due to a strong environmental effect on the acid–base 
equilibrium.52 Essentially, when located in a hydrophobic microenvironment instead of an 
aqueous solution, the pKa of an ammonium group is much lower because the protonated, 
positively charged ammonium is poorly solvated and unstable, relative to the neutral amine. 
The same could happen when the ammonium has other positively charged ions in the vicinity. 
Both situations do exist in the imprinting and binding of 10 by our cationic micelle. By taking 
the neutral amino form, template 10 can migrate deeper into the micelle of 1 and avoid 
electrostatic repulsion at the same time. Tryptophan 9, however, had to stay near the surface of 
the micelle because of its two ionic groups.53 Its advantage, of course, is the lack of electrostatic 
repulsion with the cationic micelle. In these ways, each template could optimize its interactions 
with the cationic micelle within its own capability and constraints; the end result was that the 




In Table 1, we also included two columns of cross-reactivity ratio (CRR), defined as the 
binding constant of  a guest relative to that of the template for a particular MINP. The term is 
frequently used in immunology, and measures the selectivity of our “synthetic antibodies” for 
closely related structural analogues. Based on the definition, CRR is 1 for the template and, the 
smaller the ratio for a particular guest, the weaker is the binding and the higher the selectivity 
of that MINP is for its template molecule.  
Our data shows that the zwitterionic MINP4 was able to distinguish its template from closely 
related structural analogues, regardless of the ionic characteristics of the template. For example, 
when the anionic template 8 was used as the template, zwitterionic 9 and cationic 10 gave a 
CRR of 0.59 and 0.62, respectively, for MINP4(8) (Table 1, entries 2 and 3). Although the exact 
values differed somewhat for MINP4(9) and MINP4(10), the same trend persisted, i.e., MINP 
made with the zwitterionic surfactant always bound its template more strongly than structural 
analogues (entries 4–9).  
In contrast, when cationic surfactant 1 was used to prepare MINP, a very different behavior 
was observed. Instead of favoring the template itself, MINP1(9) showed a strong preference for 
guest 8 (Table 1, entries 1–3, under MINP1). The same happened with MINP1(10). All these 
are considered imprinting failure, when the imprinted material shows weaker binding for its 
template than structural analogues. In fact, when the cationic surfactant was used to prepare 
MINPs, regardless of the template, the binding of the final MINP always followed the order of 
8 > 9 > 10. Clearly, when hydrophobic group was kept constant, the binding affinity was mainly 




The cationic MINP was not completely without merit in selectivity, however. When the 
anionic guest (8) was the template, the selectivity for the template was much higher than what 
was obtained by the zwitterionic MINP. The CRR for 9 and 10, for example, was 0.07 and 0.03 
toward MINP1(8). These numbers were much lower than the corresponding values toward 
MINP4(8), i.e., 0.59 and 0.62, respectively (Table 1, entries 2 and 3). 
As for the binding between the guests and the nonimprinted nanoparticles, the Ka values 
were very similar for NINP4 (0.05–0.06 × 105 M-1) (Table 1, entries 10–12). Thus >100:1 IF 
was consistently obtained for all three guests. The results also support the minor importance of 
electrostatic interactions for the zwitterionic micelles. For the cationic NINP1, although the 
bindings were also weak (0.01–0.09 × 105 M-1), the binding affinity did follow the expected 
order 8 > 9 > 10, indicating that the electrostatic interactions also dominated nonspecific 
binding of the cationic cross-linked micelles.   
Binding of Alkaloids by Zwitterionic MINPs. The zwitterionic cross-linkable surfactant, 
thus, gave stronger binding affinities and higher selectivities when the template was 
zwitterionic or cationic. These results encouraged us to use 4 to imprint alkaloids, an extremely 
important class of biomolecules containing basic nitrogens and frequently administered in the 
cationic salt form.28,29 As a proof of concept, we first studied  three structurally similar alkaloids 
11–13. Among the three alkaloids, 1-phenylcyclohexanecarboxylic acid derive 11 is a potential 
antispasmodic.54 Proadifen hydrochloride 12 has quite a similar structure but has completely 
different biological properties, showing inhibiting effects on cytochrome P450 enzymes55 and 
suppressing proliferation of certain cancers.56 Compound 12 is marketed under many different 
names (Ansmin, Cefadol, Celmidol, Difenidol, Maniol, Vontrol, etc.). With a slight variation 






Among the three alkaloids, 11 and 13 are quite similar and 12 is more different. For example, 
although there is a difference of ester versus hydroxyl in the center of the structure for 11 and 
13, the two are quite similar in size, shape, and amphiphilicity. Compound 12, on the other 
hand, has an extra butyl near the two phenyls and also has a diethylamino instead of piperidinyl 
group on the other end of the structure. To see whether our imprinted micelles could 
differentiate the two groups of compounds, we prepared MINPs with 4 as the cross-linkable 
surfactant for 11 and 12 and studied their binding for all three compounds. Because the 
compounds were not fluorescent, we measured the binding by ITC. 
Table 2 shows that both MINP4(11) and MINP4(12) bound their template more strongly than 
other alkaloids. The binding constant for 11 and 12 was 3.15 and 4.60 × 105 M-1, respectively, 
by their own MINP receptor (entries 1 and 5). When 11 was used as the template, CRR was 
0.16 for 12 and 0.63 for 13. Thus, 13 was more similar to 11 than 12, as far as the binding was 
concerned. When 12 was used as the template, CRR was 0.08 for 11 and 0.05 for 13. Thus, 
once again, 11 and 13 were quite similar and differed quite a bit from 12, on the basis of their 








Table 2. Binding data for MINPs obtained by ITC.a 
entry template guest N Ka (10







1 11 11 0.8 ± 0.2 3.15 ± 0.33 1 7.5 26.6 ± 2.4 -19.1 
2 11 12 0.8 ± 0.1 0.516 ± 0.048 0.16 6.4 9.8 ± 1.3 -3.4 
3 11 13 0.7 ± 0.1 1.97 ± 0.14 0.63 7.2 31.5 ± 3.1 -24.3 
4 12 11 1.3 ± 0.2 0.360 ± 0.028 0.08 6.2 2.5 ± 0.3 3.7 
5 12 12 0.7 ± 0.1 4.60 ± 0.67 1 7.7 11.1 ± 3.1 -3.4 
6 12 13 1.1 ± 0.1 0.222 ± 0.034 0.05 5.9 4.3 ± 0.5 1.6 
7 14 14 0.8 ± 0.1 7.81 ± 0.31 - 8.0 3.3 ± 0.6 4.7 
a Binding was measured in 50 mM Tris buffer (pH = 7.4). The titrations were performed in 
duplicates and the errors between the runs were <20%.  
 
Unlike molecular synthesis of receptors that gets more difficult with increasing complexity 
of ligands, molecular imprinting of complex guests can be as straightforward as that of simple 
ones. Vinblastine 14 is a dimeric indole-based alkaloid with a very complex structure. It is able 
to inhibit the formation of microtubules57,58 and normally administered together with other 
anticancer drugs against a wide range of cancers. In our hands, it could be imprinted as easily 
as the other much simpler templates. We also measured the binding of the alkaloid by the 
MINP. The binding constant was 7.81 × 105 M-1 (Table 2, entry 7), in line with those for other 







Synthetic receptors have potential applications in the isolation, extraction, and monitoring of 
biologically interesting molecules including drugs and natural products. They could also be 
used to probe or intervene biological interactions. Despite all these applications, design and 
synthesis of molecular receptors become too difficult as the guest gets more complicated in 
structure and larger in size. This work shows that micellar imprinting affords a convenient 
method to create protein-sized, water-soluble organic nanoparticles for natural products/drugs. 
It also revealed that zwitterionic cross-linkable surfactant 4 outperformed the cationic one (1) 
in most cases when the guests carried identical hydrophobes but different ionic groups. 
Imprinted receptors prepared with this surfactant was able to categorize and recognize closely 
related alkaloids. The one-pot, 2-day synthesis of MINP at room temperature was 
straightforward to perform for complex as well as simple alkaloids. Given that many important 
alkaloids are isolated from natural sources—e.g., vinblastine from the leaves of Catharanthus 
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Experimental Section 
General Method. Routine 1H and 13C NMR spectra were recorded on a 400 and 600 MHz 
NMR spectrometer. ESI-MS mass was recorded on Shimadzu LCMS-2010 mass spectrometer. 
Dynamic light scattering (DLS) data were recorded at 25 °C using PDDLS/CoolBatch 90T with 
PD2000DLS instrument.  Isothermal titration calorimetry (ITC) was performed using a 
MicroCal VP-ITC Microcalorimeter with Origin 7 software and VPViewer2000 (GE 
Healthcare, Northampton, MA). Syntheses of compounds 1–3 and 6 were reported 
previously.21  
Compound 4. N,N-Diisopropylethylamine (DIPEA) (84 mg, 0.65 mmol) was added slowly 
to stirred solution of 6 (135 mg, 0.5 mmol) and 7  (71 mg, 0.5 mmol) in anhydrous THF (2 mL) 
at 0 °C. The reaction mixture was warmed up to room temperature. After 2 h, the mixture was 
filtered through a pad of celite and the filtrate was concentrated under reduced pressure. The 
colorless oil was dissolved in anhydrous methylene chloride (3 mL) at 0 °C, followed by 
addition of trimethylsilyl triflate (111 mg, 0.5 mmol) and tripropargylamine (200 mg, 1.5 
mmol). The reaction mixture was warmed to room temperature and stirred for 12 h. The 
reaction mixture was diluted with chloroform (10 mL) and neutralized with saturated sodium 
bicarbonate solution. The organic layer was separated, dried over anhydrous Na2SO4, and 
concentrated under reduced pressure. The residue was purified by column chromatography over 
silica gel using 4:1 methylene chloride/methanol and then 55:45:3 methylene 
chloride/methanol/water as eluents to afford a colorless oil (139 mg, 55%). 1H NMR (600 MHz, 




(s, 2H), 3.84 (m, 2H), 3.42 (s, 3H), 1.94 (s, 3H), 1.65 (m, 4H), 1.19 (m, 16H). 13C{H} NMR 
(100 MHz, CDCl3, δ): 167.6, 136.5, 125.2, 83.4, 70.8, 66.0, 60.20, 58.8, 51.2, 30.9, 30.9, 29.72, 
29.70, 29.63, 29.57, 29.3, 28.6, 26.0, 25.91 18.3. HRMS (ESI/QTOF) m/z: [M + H]+ calcd for 
C27H43NO6P, 508.2823; found 508.2835. 
Preparation of MINPs and NINPs. Preparation of MINP1 followed previously reported 
procedures and typical yields were 70–80%.21 In the preparation of MINP4, copper chloride 
used in the click reaction (for surface-cross-linking and functionalization) precipitated in the 
presence of 4. The click reaction was performed with copper chloride as the precatalyst with 
additional 4 equivalents of a tridentate ligand N,N,N′,N′′,N′′-pentamethyldiethylenetriamine 
(PMDTA).59 For the purification of MINP4, the final reaction mixture was poured into acetone 
(8 mL). The precipitate was collected by centrifugation and washed with a mixture of methanol 
(5 mL) three times. The off-white powder was dried in air to afford the final MINPs with 
typically 70% yield. The preparation of nonimprinted nanoparticles (NINP1 and NINP4) 
followed the same procedures, except that the template was not used. 
Determination of Binding Constants by Fluorescence Titration. A typical procedure is as 
follows. A stock solution containing MINP4(8) (200 µM) was prepared in 50 mM Tris buffer 
(pH = 7.4). Aliquots (2 µL) of the MINP stock solution were added to 2.00 mL of the solutions 
of 8–10 in the same buffer (2.0 µM). After each addition, the sample was allowed to sit for 1 
min at room temperature before the fluorescence spectrum was collected. The excitation 
wavelength (λex) was 300 nm. The excitation slit width was 10 nm, and the emission slit width 
was 10 nm. The binding constant was obtained by nonlinear least squares fitting of the emission 





Figure S1. 1H NMR spectra of (a) 1 in CDCl3, (b) alkynyl-SCM in D2O, and (c) MINP1(8) in 
D2O. 
 
Figure S2. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP1(8) 





Figure S3. The correlation curve and the distribution of the molecular weight for MINP1(8) 
from the DLS. The PRECISION DECONVOLVE program assumes the intensity of scattering 
is proportional to the mass of the particle squared. If each unit of building block for the 
MINP1(8) is assumed to contain one molecule of compound 1 (MW = 465 g/mol), 1.2 
molecules of compound 2 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), and 
0.8 molecules of compound 3 (MW = 264 g/mol), the molecular weight of MINP1(8) translates 
to 51 [= 52900 / (465 + 1.2×172 + 130 + 0.8×264)] of such units.   
 







Figure S5. 1H NMR spectra of (a) 4 in CDCl3, (b) alkynyl-SCM in D2O, and (c) MINP4(8) in 
D2O. 
 
Figure S6. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP4(8) 




                  
Figure S7. The correlation curve and the distribution of the molecular weight for MINP4(8) 
from the DLS. The PRECISION DECONVOLVE program assumes the intensity of scattering 
is proportional to the mass of the particle squared. If each unit of building block for the 
MINP4(8) is assumed to contain one molecule of compound 4  (MW = 508 g/mol), 1.2 
molecules of compound 2 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), and 
0.8 molecules of compound 3 (MW = 264 g/mol), the molecular weight of MINP4(8) translates 
to 51 [= 53400 / (508 + 1.2×172 + 130 + 0.8×264)] of such units.   
 







Figure S9. 1H NMR spectra of (a) 4 in CDCl3, (b) alkynyl-SCM in D2O, and (c) MINP4(11) in 
D2O. 
 
Figure S10. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP4(11) 
after purification.  





Figure S11. The correlation curve and the distribution of the molecular weight for MINP4(11) 
from the DLS. The PRECISION DECONVOLVE program assumes the intensity of scattering 
is proportional to the mass of the particle squared. If each unit of building block for the 
MINP4(11) is assumed to contain one molecule of compound 4  (MW = 508 g/mol), 1.2 
molecules of compound 2 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), and 
0.8 molecules of compound 3 (MW = 264 g/mol), the molecular weight of MINP4(11) translates 






Figure S12. 1H NMR spectra of (a) 4 in CDCl3, (b) alkynyl-SCM in D2O, and (c) MINP4(12) 
in D2O. 
 
Figure S13. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP4(12) 





Figure S14. The correlation curve and the distribution of the molecular weight for MINP4(12) 
from the DLS. The PRECISION DECONVOLVE program assumes the intensity of scattering 
is proportional to the mass of the particle squared. If each unit of building block for the 
MINP4(12) is assumed to contain one molecule of compound 5  (MW = 508 g/mol), 1.2 
molecules of compound 2 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), and 
0.8 molecules of compound 3 (MW = 264 g/mol), the molecular weight of MINP4(12) translates 






Figure S15. 1H NMR spectra of (a) 4 in CDCl3, (b) alkynyl-SCM in D2O, and (c) MINP4(14) 
in D2O. 
 
Figure S16. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP4(14) 





Figure S17. The correlation curve and the distribution of the molecular weight for MINP4(14) 
from the DLS. The PRECISION DECONVOLVE program assumes the intensity of scattering 
is proportional to the mass of the particle squared. If each unit of building block for the 
MINP4(14) is assumed to contain one molecule of compound 5  (MW = 508 g/mol), 1.2 
molecules of compound 2 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), and 
0.8 molecules of compound 3 (MW = 264 g/mol), the molecular weight of MINP4(14) translates 






Figure S18. (a) Fluorescence emission spectrum of MINP4(8) at different concentrations in 50 
mM Tris buffer (pH 7.4).  
 
Figure S19. (a) Fluorescence emission spectra of guest 8 (λex = 300 nm) upon addition of 
different concentrations of NINP4 in 50 mM Tris buffer (pH 7.4). [8] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm; 





Figure S20. (a) Fluorescence emission spectra of guest 9 (λex = 300 nm) upon addition of 
different concentrations of NINP4 in 50 mM Tris buffer (pH 7.4). [9] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of 9 at 363 nm to a 1:1 binding isotherm; 
corresponding to entry 10 in Table 1. 
   
Figure S21. (a) Fluorescence emission spectra of guest 9 (λex = 300 nm) upon addition of 
different concentrations of MINP4(8) in 50 mM Tris buffer (pH 7.4). [9] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 9 at 363 nm to a 1:1 binding isotherm; 





Figure S22. (a) Fluorescence emission spectra of guest 9 (λex = 300 nm) upon addition of 
different concentrations of MINP1(8) in 50 mM Tris buffer (pH 7.4). [9] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 9 at 363 nm to a 1:1 binding isotherm; 






Figure S23. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of MINP4(8) in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding 
isotherm; corresponding to entry 3 in Table 1. 
 
Figure S24. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of MINP1(8) in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding 






Figure S25. (a) Fluorescence emission spectra of guest 8 (λex = 300 nm) upon addition of 
different concentrations of MINP4(9) in 50 mM Tris buffer (pH 7.4). [8] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm; 
corresponding to entry 4 in Table 1. 
 
 
Figure S26. (a) Fluorescence emission spectra of guest 8 (λex = 300 nm) upon addition of 




Nonlinear least squares fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm; 
corresponding to entry 4 in Table 1. 
   
Figure S27. Fluorescence Titration of 9 by MINP4(9) (a) Fluorescence emission spectra of 
guest 9 (λex = 300 nm) upon addition of different concentrations of MINP4(9) in 50 mM Tris 
buffer (pH 7.4). [9] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 9 
at 363 nm to a 1:1 binding isotherm; corresponding to entry 5 in Table 1. 
 
Figure S28. Fluorescence Titration of 9 by MINP1(9) (a) Fluorescence emission spectra of 
guest 9 (λex = 300 nm) upon addition of different concentrations of MINP1(9) in 50 mM Tris 
buffer (pH 7.4). [9] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 9 





Figure S29. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of MINP4(9) in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding 
isotherm; corresponding to entry 6 in Table 1. 
 
 
Figure S30. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of MINP1(9) in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding 





Figure S31. (a) Fluorescence emission spectra of guest 8 (λex = 300 nm) upon addition of 
different concentrations of MINP4(10) in 50 mM Tris buffer (pH 7.4). [8] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm; 
corresponding to entry 7 in Table 1. 
 
Figure S32. (a) Fluorescence emission spectra of guest 8 (λex = 300 nm) upon addition of 
different concentrations of MINP1(10) in 50 mM Tris buffer (pH 7.4). [8] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm; 






Figure S33. (a) Fluorescence emission spectra of guest 9 (λex = 300 nm) upon addition of 
different concentrations of MINP4(10) in 50 mM Tris buffer (pH 7.4). [9] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 9 at 363 nm to a 1:1 binding isotherm; 
corresponding to entry 8 in Table 1. 
 
Figure S34. (a) Fluorescence emission spectra of guest 9 (λex = 300 nm) upon addition of 
different concentrations of MINP1(10) in 50 mM Tris buffer (pH 7.4). [9] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 9 at 363 nm to a 1:1 binding isotherm; 





Figure S35. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of MINP4(10) in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding 
isotherm; corresponding to entry 9 in Table 1. 
 
Figure S36. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of MINP1(10) in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding 





Figure S37. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of NINP4 in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding isotherm; 
corresponding to entry 11 in Table 1. 
 
Figure S38. (a) Fluorescence emission spectra of guest 8 (λex = 300 nm) upon addition of 
different concentrations of NINP1 in 50 mM Tris buffer (pH 7.4). [8] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm; 





Figure S39. (a) Fluorescence emission spectra of guest 9 (λex = 300 nm) upon addition of 
different concentrations of NINP1 in 50 mM Tris buffer (pH 7.4). [9] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of 9 at 363 nm to a 1:1 binding isotherm; 
corresponding to entry 12 in Table 1. 
 
Figure S40. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of NINP1 in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding isotherm; 










Figure S41. ITC titration curves obtained at 298 K for the titration of MINP1(8) with guest 8  
in 50 mM Tris buffer (pH 7.4). The data correspond to entry 9 in Table 1. The top panel shows 
the raw calorimetric data. The area under each peak represents the amount of heat generated at 
each ejection and is plotted against the molar ratio of MINP to the substrate. The solid line is 
the best fit of the experimental data to the sequential binding of N equal and independent 
binding sites on the MINP. The heat of dilution for the substrate, obtained by adding the 
substrate to the buffer, was subtracted from the heat released during the binding. Binding 







































































Figure S42. ITC titration curves obtained at 298 K for the titration of MINP4(11) with alkaloid 
guest 11 (a), MINP4(11) with guest 12 (b),  and MINP4(11) with guest 13 (c)  in 50 mM Tris 
buffer (pH 7.4). The data correspond to entries 1-3, respectively, in Table 2. The top panel 
shows the raw calorimetric data. The area under each peak represents the amount of heat 
generated at each ejection and is plotted against the molar ratio of MINP to the substrate. The 
solid line is the best fit of the experimental data to the sequential binding of N equal and 
independent binding sites on the MINP. The heat of dilution for the substrate, obtained by 
adding the substrate to the buffer, was subtracted from the heat released during the binding. 













































































































































Figure S43. ITC titration curves obtained at 298 K for the titration of MINP4(12) with alkaloid 
guest 11 (a), MINP4(12) with guest 12 (b), and MINP4(12) with guest 13 (c) in 50 mM Tris 
buffer (pH 7.4). The data correspond to entries 4-6, respectively, in Table 2. The top panel 
shows the raw calorimetric data. The area under each peak represents the amount of heat 
generated at each ejection and is plotted against the molar ratio of MINP to the substrate. The 
solid line is the best fit of the experimental data to the sequential binding of N equal and 
independent binding sites on the MINP. The heat of dilution for the substrate, obtained by 
adding the substrate to the buffer, was subtracted from the heat released during the binding. 
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Figure S44. ITC titration curves obtained at 298 K for the titration of MINP4(14) with alkaloid 
guest 14 in 50 mM Tris buffer (pH 7.4). The data correspond to entries 7 in Table 2. The top 
panel shows the raw calorimetric data. The area under each peak represents the amount of heat 
generated at each ejection and is plotted against the molar ratio of MINP to the substrate. The 
solid line is the best fit of the experimental data to the sequential binding of N equal and 
independent binding sites on the MINP. The heat of dilution for the substrate, obtained by 
adding the substrate to the buffer, was subtracted from the heat released during the binding. 


































































Figure S45. (a) Fluorescence emission spectra of guest 8 (λex = 300 nm) upon addition of 
different concentrations of MINP4(11) in 50 mM Tris buffer (pH 7.4). [8] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 8 at 363 nm to a 1:1 binding isotherm; 
corresponding to entry 1 in Table 2S. 
 
Figure S46. (a) Fluorescence emission spectra of guest 9 (λex = 300 nm) upon addition of 
different concentrations of MINP4(11) in 50 mM Tris buffer (pH 7.4). [9] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 9 at 363 nm to a 1:1 binding isotherm; 






Figure S47. (a) Fluorescence emission spectra of guest 10 (λex = 300 nm) upon addition of 
different concentrations of MINP4(11) in 50 mM Tris buffer (pH 7.4). [10] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of 10 at 363 nm to a 1:1 binding 
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Abstract   
    Folate receptors are overexpressed on cancer cells and frequently used for targeted delivery. 
Creation of synthetic receptors to bind folic acid and analogues in water, however, is 
challenging because of its complex hydrogen-bonding patterns and competition for hydrogen 
bonds from the solvent. Micellar imprinting within cross-linkable surfactants circumvented 
these problems because the nonpolar micellar environment strengthened the hydrogen bonds 
between the amide group in the surfactant and the template molecule. Polymerizable 
thiouronium functional monomers further enhanced the binding through hydrogen-bond-
reinforced ion pairs with the glutamate moiety of folate. The resulting imprinted micelles were 
able to bind folate and their analogues with submicromolar affinity and distinguish small 
changes in the hydrogen bonding patterns, as well as the number/position of carboxylic acids. 
The binding constant obtained was 2–3 orders of magnitude higher than those reported for small 




For example, the relative contributions of different segments of the molecule to the binding 
followed the order of carboxylates > pyrimidine ring > pyrazine ring.   
Introduction 
Biological systems rely on molecular recognition for important processes such as binding, 
catalysis, and transport. Because individual noncovalent interactions are quite weak, they are 
used together to achieve sufficient strength. Chemists over the last several decades have used 
the same strategy to construct receptors for ions and small organic molecules, mainly in organic 
solvents.1,2  
To bind a guest molecule with high affinity and selectivity, its receptor needs to have a highly 
complementary binding interface for the guest. Macrocycles are a perfect platform for 
receptors, as long as their concave structure has the appropriate size and functionality for the 
guest molecule. A more recent platform is linear foldamers,3-7 with a particular benefit of using 
guest-triggered conformational changes to amplify the guest binding.8,9  
Both macrocycles and foldamers represent the molecular approach to the construction of 
receptors. Herein, the receptor, typically larger than the guest molecule, is built step-by-step to 
encompass the guest. As the guest molecule becomes more complex, the receptors necessarily 
grow in size and complexity and their synthesis could become very difficult. 
Molecular recognition in water takes the challenge to the next level,10,11 as hydrogen bonds, 
one of the best tools for directional molecular interaction, are compromised by competition 
from the solvent. Furthermore, when the receptor is built from a molecular scaffold, water-
solubilizing groups need to be installed on the structure, in addition to the binding groups. As 
we move from simple organic guests to more complex biological molecules, design and 




Molecular imprinting is a very different approach to constructing receptors.12-22  The method 
aims to trap the noncovalent or covalent complex between the template/guest molecule and 
functional monomers (FMs) in a polymeric matrix by heavy cross-linking. Removal of the 
templates leaves behind guest-complementary binding sites in the matrix, potentially with a 
high level of fidelity. In this method, the binding site is formed by facile covalent capture 
instead of total synthesis, making the synthesis much easier to perform. Not surprisingly, since 
their discovery, molecularly imprinted polymer (MIPs) have been used by researchers of 
diverse backgrounds for applications including separation, enzyme-mimetic catalysis, and 
chemical sensing. Over the years, many different techniques have been developed to improve 
the properties of traditional MIPs, including imprinting unimolecularly within dendrimers,23,24 
on polymeric nanoparticles,25-32 and within micro/nanogels33-38   
Folic acid is an important biological molecule. Because folate receptors are overexpressed on 
many cancerous cells,39 folic acids are frequently used for targeted delivery of anticancer 
drugs.40,41 Creation of synthetic receptors for folic acid illustrates the typical challenges in the 
molecular recognition of biomolecules in water.42-46 The molecule is highly functional, with a 
glutamate coupled to a pteroate moiety. It is fully water-soluble with numerous hydrogen-bond 
donors and acceptors and two ionizable carboxylic acids. A particular challenge with 
biomolecules is their selective recognition among close relatives: molecules 2–4 differ subtly 
from folic acid, sometimes by only one or two hydrogen-bond donor/acceptor. Yet, they play 





Chart 1. Structures of folic acid and analogues, with the differences from folic acid highlighted 
by blue circles. 
These challenges, together with our interest of designing biomimetic receptors,47-49 prompted 
us to develop synthetic receptors for folic acid and analogues. In this paper, we report that 
highly selective folate receptors could be prepared by molecular imprinting within doubly 
cross-likable micelles. The resulting molecularly imprinted nanoparticles (MINPs) use 
hydrogen bonds, salt bridges, and hydrophobic interactions to achieve strong and selective 
binding. The binding constant obtained by our receptor was 2–3 orders of magnitude higher 
than those reported in the literature by small-molecule receptors. The materials bridge the gap 
between molecular receptors and macroscopic MIPs. Similar to traditional MIPs, they can be 
prepared conveniently in one-pot reaction without special techniques. Unlike macroscopic 
polymers, however, they behave like soluble molecular receptors due to their nanodimension 
and a controllable number of binding sites.      
Results and Discussion 
Design and Synthesis of Functionalized MINPs. Preparation of MINP receptors is shown 
in Scheme 1. Cross-linkable surfactant 5 contains two sets of orthogonal cross-linkable groups 




surface by the Cu(I)-catalyzed click reaction with diazide 6.56,57 The surface-cross-linked 
micelle was further functionalized by the click reaction with monoazide 7. The 
functionalization decorates the micelle with a layer of hydrophilic ligands to improve its water-
solubility. The micelle contained divinylbenzene (DVB) and DMPA (a photolytic radical 
initiator). Free radical polymerization was initiated normally after the surface-cross-linking and 
functionalization to cross-link the core between the methacrylate of 5 and DVB. The template 
molecule typically had significant hydrophobicity and was incorporated into the micelle very 
easily. It served as a place holder inside the micelle as the surface–core double cross-linking 
“solidified” the micelle. Once the template was removed by repeated solvent washing, the 
resulting nanoparticle possessed a binding site complementary to the template molecule. The 
surfactant/template ratio was typically maintained at 50:1 in the preparation because dynamic 
light scattering (DLS) showed that each MINP consisted of approximately 50 (cross-linked) 
surfactants. The 50:1 surfactant/template ratio translated to an average of one binding site per 
nanoparticle. We have shown that this number is fully tunable, simply by using different 





Scheme 1. Preparation of MINP from templated polymerization of cross-linkable micelle. 
  The detailed procedures for the MINP preparation are reported in the Experimental Section. 
In general, the surface-cross-linking and core-polymerization/cross-linking was monitored by 
1H NMR spectroscopy and DLS (Supporting Information).51 As the surfactant and DVB (core-
cross-linker) underwent free radical polymerization, 1H NMR spectroscopy showed 
disappearance of alkenic protons. DLS, on the other hand, revealed an increase in size for the 
nanoparticles as surface ligands were attached and a slight decrease in size when core-
polymerization shrank the cross-linked micelles. DLS could also help us estimate the molecular 
weight of the MINP. The surface-cross-linking has been confirmed by mass spectrometry (after 
cleaving the surface-cross-linkages)56 and the DLS size by transmission electron microscopy 
(TEM).58 
Binding Properties of MINPs. Folic acid is rich in hydrogen-bonding functionalities and 
has two carboxylic acids. This was why we used amide-functionalized surfactant 5 in the 




usage of a cationic cross-linkable surfactant is envisioned to help its inclusion in the micelle. 
Once incorporated into the micelle, folic acid is expected to stay close to the micellar surface 
to be solvated by water, due to its strong hydrophilicity. The amide bond of 5 is only two 
carbons away from the ammonium headgroup and thus should be very close to the surface as 
well. We reasoned that the numerous surfactant molecules surrounding the template would 
hydrogen-bond with it using the amide. Although competition from solvent often makes 
hydrogen bonds ineffective for molecular recognition in water, the hydrophobic 
microenvironment of a micelle is known to strengthen hydrogen bonds.59,60 As a comparison, 
we prepared a MINP from compound 8, another cross-linkable surfactant we frequently 
used.61,62 It has little hydrogen-bonding ability in the headgroup but the same cross-linkable 
functionalities (tripropargylammonium headgroup and methacrylate on the hydrophobic tail). 
As will be shown by the binding data (vide infra), surfactant 5 afforded a MINP with 
significantly stronger binding than 8.    
 
To recognize the glutamate moiety, we included FM 9 in the formulation. It is amphiphilic, 
just like the cross-linkable surfactant. The two hydrophobic aromatic rings help the molecule 
stay within the micelle. The thiouronium group, similar to guanidinium or amidinium,63-66  is 
known to form strong hydrogen-bond-reinforced salt bridge with carboxylate.52 Its vinyl group 





Folic acid is weakly fluorescent. As different concentrations of MINP5(1)—i.e., MINP 
prepared with cross-linkable surfactant 5  and template 1—were added to folic acid in 50 mM 
Tris buffer (pH 7.4), its fluorescence was slightly quenched (Figure 1a). Two isoemissive points 
were observed at 417 and 511 nm, indicating that the titration caused a continuous transition 
from the free to the bound guest. The emission intensity at 448 nm fit nicely to a 1:1 binding 
isotherm, yielding a binding constant (Ka) of (17.2 ± 2.7) × 10
5 M-1 in Tris buffer (Figure 1b). 
The submicromolar binding affinity was very impressive for a completely water-soluble guest. 
In comparison, molecularly constructed receptors in the literature were reported to bind folate 
with Ka = 10
2–104 M-1.45 The 1:1 binding stoichiometry was confirmed in our case by the Job 
plot, which showed a clear maximum at a molar fraction of 0.5 (Figure 1c).    
 
Figure 1. (a) Emission spectra of folic acid 1 in the presence of 0–4.5 µM of MINP5(1) in 50 
mM Tris bugger (pH 7.4). The MINP was prepared with 2 equiv FM 9 to bind the glutamate. 




intensity at 448 nm to a 1:1 binding isotherm. (c) Job plot for the binding of 1 by MINP5(1), in 
which the emission intensity at 448 nm was plotted against the molar fraction of 1, at a constant 
total concentration of 10.0 μM in 50 mM Tris buffer (pH = 7.4). 
We also confirmed the binding constant obtained from the fluorescence titration by 
isothermal titration calorimetry (ITC). It is considered one of the most reliable methods for 
studying intermolecular interactions.67  It has the benefit of giving a number of important 
parameters including binding enthalpy (ΔH) and the number of binding sites per particle (N), 
in addition to the binding constant. The binding free energy (ΔG) can be calculated from Ka 
using equation -ΔG = RTln(Ka), and ΔS from ΔG and ΔH. The ITC titration of 1 showed a 
negative/favorable enthalpy. The data afforded a Ka value of (17.0 ± 1.0) × 10
5 M-1 (Table 1, 
entry 1), in excellent agreement with the value obtained by fluorescence titration. The ITC 
titration gave the number of binding site of N = 1.2 ± 0.4, consistent with our surfactant/template 
ratio in the preparation and also the Job plot.      
Table 1 summarizes the binding data obtained in the study. The binding data were generally 
obtained from ITC and selected examples were verified by fluorescence titration, with the Ka 







































Figure 2. ITC curve obtained at 298.15 K from titration of MINP5(1) with 1 in 50 mM Tris 
buffer (pH = 7.4). The MINP was prepared with 2 equiv FM 9 to bind the glutamate. MINP5(1) 
= 10 µM in the cell. The concentration of 1 in the syringe was 0.2 mM. 
Entries 1–4 of Table 1 show the effects of FM 9 on the MINP binding. As the amount of the 
FM increased in the formulation, the binding constant of the corresponding MINP for folic acid 
(1) peaked at 2 equiv 9. Since folic acid has two carboxylates, the results indicate that a 1:1 
stoichiometry is optimal for the imprinting and binding. MINP5(1) prepared without FM 9 also 
gave a significant binding constant (Ka = 4.55 × 10
5 M–1). Thus, even without the thiouronium 




Table 1. Binding data for MINPs (obtained by ITC unless indicated otherwise)a 










1 MINP5(1) 0 equiv 9 1 7.7 0.9 ± 0.3 4.55 ± 1.3  
(4.60 ± 1.40) 
3.4 ± 1.1 4.3 
2 MINP5(1) 1 equiv 9 1 8.2 0.9 ± 0.1 10.1 ± 2.5  
(10.0 ± 2.2) 
1.0 ± 0.1 7.2 
3 MINP5(1) 2 equiv 9 1 8.5 1.2 ± 0.4 17.0 ± 1.0  
(17.2 ± 2.7) 
7.3 ± 1.7 1.2 
4 MINP5(1) 3 equiv 9 1 8.4 0.8 ± 0.1 16.0 ± 1.0  
(16.1 ± 2.3) 
5.8 ± 0.8 2.6 
5 MINP8(1) 2 equiv 9 1 7.4 0.7 ± 0.2 2.47 ± 0.14 3.8 ± 0.5 3.6 
6 MINP5(1) 2 equiv 9 2 7.5 0.8 ± 0.2 3.50 ± 1.0  
(3.70 ± 0.94) 
9.7 ± 1.3 -2.2 
7 MINP5(1) 2 equiv 9 3 5.9 0.9 ± 0.1 0.217 ± 0.052 19.5 ± 1.7 -13.6 
8 MINP5(1) 2 equiv 9 4 8.1 1.3 ± 0.1 9.01 ± 0.22 15.2 ± 1.3 -7.1 
9 MINP5(2) 2 equiv 9 1 7.4 0.8 ± 0.1 2.81 ± 0.31 3.2 ± 0.6 4.2 
10 MINP5(2) 2 equiv 9 2 8.4 1.2 ± 0.3 13.6 ± 1.6 10.9 ± 3.0 -2.5 
11 MINP5(2) 2 equiv 9 3 5.6 1.0 ± 0.2 0.127 ± 0.011 1.3 ± 0.2 4.3 




a The titrations were generally performed in duplicates in 50 mM Tris buffer (pH = 7.4) and the 
errors between the runs were <20%. The binding constants in parentheses were from 
fluorescence titration and thus the number of binding sites and binding enthalpy/entropy were 
not available. b The subscript denotes the cross-linkable surfactant used in the MINP synthesis 
and the number in parentheses the template molecule. c Binding was too weak to be detected 
by ITC. c N is the number of binding site per nanoparticle measured by ITC. 
 
and clear trends in the binding constants ruled out any significant nonspecific binding during 
the titrations.   
Entry 5 shows the binding of MINP8(1) prepared with 2 equiv FM 9. The binding constant 
(Ka = 2.47  10
5 M–1) was 1/7 of that from MINP5(1) prepared under the same conditions. The 
results support the importance of the amide groups in the imprinting, most likely from the 
proposed hydrogen-bonding interactions mentioned above. 
Compounds 2–4 are close structural analogues of folic acid (1). Aminopterin 2 has an 
identical glutamate moiety and a 4-aminobenzoyl spacer as folic acid. The only difference is at 
the left end of the molecule, in the hydrogen-bonding pattern. Instead of D-D-A in the 
pyrimidine ring of 1, compound 2 has a D-A-D motif, with everything else being the same 
(Chart 1). Yet, MINP5(1) showed significant selectivity, with 2 only bound by MINP5(1) with  
Ka = 3.50 × 10
5 M–1 (Table 1, entry 6). This number is about 1/5 of that for 1, corresponding to 
about 1 kcal/mol difference in the binding free energy. Clearly, hydrogen bonds played an 
important role in the imprinting and binding of the folate derivatives, as supported by our earlier 
data. This is an important feature of our imprinting method. Molecular imprinting in water 
traditionally is considered a highly challenging topic.68 In our case, the micellar environment 
circumvented the problem of solvent competition. Given the polarity of folic acid, it must stay 
near the surface of the micelle. It is very good news that hydrogen bonds between the amide of 




Pteroic acid 3 is missing the glutamate of folic acid. Its binding by MINP5(1), thus, tests the 
importance of the carboxylic acids in the molecular imprinting. The binding constant was even 
weaker, with Ka = 0.217 × 10
5 M–1 (Table 1, entry 7) or nearly 1/80 of the value for 1. Thus, 
the carboxylates contributed very strongly to the binding. The result is in agreement with entries 
1–4, illustrating the importance of thiouronium FM 9 in our study. 
Tetrahydrofolic acid 4 is similar to 2 in that the hydrogen-bonding motifs of the molecule is 
changed by the reduction of the pyrazine ring. Instead of two hydrogen-bond acceptors in 1, 
the same place now has two hydrogen-bond donors instead. MINP5(1) again was able to detect 
the change, with Ka = 9.01 × 10
5 M–1 (Table 1, entry 8). This binding constant is stronger than 
that for 2 (entry 6) by nearly 3 times,  suggesting that the pyrazine part of the molecule played 
a less important role than pyrimidine in the molecular imprinting and binding of the receptor. 
The benefit of creating receptors by molecular imprinting is that different receptors can be 
prepared with the same ease, without the need of any individual design, as formation of the 
binding pocket is taken care of by similar template–FM complexation and covalent capture. We 
thus prepared MINP5(2) following similar procedures, with aminopterin as the template 
molecule. As shown by the binding data (Table 1, entries 9–12), this receptor showed as good 
binding properties as MINP5(1): the receptor shows the strongest binding for its own template 
(2) among the structural analogues. This is another indication for the success of the imprinting. 
The guest that was bound most weakly was pteroic acid 3, once again highlighting the key roles 
of the thiouronium–carboxylate salt bridge in the imprinting and binding. If the change around 
the pyrazine ring between 1 and 4 were detected with a little difficulty by MINP5(1) (relatively 
speaking), MINP5(2) had no problem distinguishing 4—its binding was nearly one order of 




difference between 1 and 4 are in the pyrazine, which according to the earlier discussion 
contributed not as importantly as other parts of the molecule to the binding. The difference 
between 2 and 4 are in both the pyrazine and the pyrimidine ring in the hydrogen-bonding 
motifs. Since the latter seemed to be key contributors to the binding, differentiation between 
these two molecules is expected to be easier than between 1 and 2. 
Conclusions 
Although molecular recognition in water is a very challenging topic in supramolecular 
chemistry,10,11 this work shows that molecular imprinting in cross-linked micelles is an 
effective and convenient solution to the problem. Despite the complexity of folate derivatives 
and their subtle structural differences, our MINP receptors easily distinguished them in the 
binding. The initial applications of MINPs focused on relatively hydrophobic molecules.51,69 
This work demonstrates that very hydrophilic molecules can be imprinted just as easily, as long 
as appropriate FMs are present. It also shows that MINP could be used to reveal the relative 
contributions of different functional groups to the binding, by comparing structural analogues 
in the binding. In the case of MINP receptors for folate, the relative contributions followed the 
order of carboxylates > pyrimidine > pyrazine. This is an extremely useful feature of our 
imprinted receptors, as it can help reveal the effectiveness of different functional groups in 
molecular recognition and allow researchers to focus on the most effective groups. Although it 
is difficult to measure the importance of hydrophobic interactions in folate recognition directly, 
the interactions are expected to be the “background”, always present in molecular recognition 
in water. Even for the binding of carbohydrates (which typically lack any significantly 
hydrophobic groups) by lectins (their protein receptors in nature), release of water-molecules 




binding, the imprinted binding site of MINP is occupied by water molecules. Even though folic 
acid itself is not very hydrophobic, its binding releases these “high-energy” water molecules, 
similar to the binding of carbohydrates by lectins.  
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Experimental Section 
Syntheses of compounds 5,50 6–8,51  and 952 were previously reported.  
Preparation of Molecularly Imprinted Nanoparticles (MINPs). A typical procedure is as 
follows.51 To a micellar solution of compound 5 (10.2 mg, 0.02 mmol) in H2O (2.0 mL), 
divinylbenzene (DVB, 2.8 μL, 0.02 mmol), compound 1 in H2O (10 μL of a solution of 18.5 
mg/mL, 0.0004 mmol), and 2,2-dimethoxy-2-phenylacetophenone (DMPA,10 μL of a 12.8 
mg/mL solution in DMSO, 0.0005 mmol) were added. The mixture was subjected to 
ultrasonication for 10 min before compound 6 (4.13 mg, 0.024 mmol), CuCl2 (10 μL of a 6.7 
mg/mL solution in H2O, 0.0005 mmol), and sodium ascorbate (10 μL of a 99 mg/mL solution 
in H2O, 0.005 mmol) were added. After the reaction mixture was stirred slowly at room 
temperature for 12 h, compound 7 (10.6 mg, 0.04 mmol), CuCl2 (10 μL of a 6.7 mg/mL solution 
in H2O, 0.0005 mmol l), and sodium ascorbate (10 μL of a 99 mg/mL solution in H2O, 0.005 
mmol) were added. After being stirred for another 6 h at room temperature, the reaction mixture 
was transferred to a glass vial, purged with nitrogen for 15 min, sealed with a rubber stopper, 
and irradiated in a Rayonet reactor for 12 h. 1H NMR spectroscopy was used to monitor the 




collected by centrifugation and washed with a mixture of acetone/water (5 mL/1 mL) three 
times. The crude produce was washed by methanol/acetic acid (5 mL/0.1 mL) three times until 
the emission peak at 448 nm (for the dansyl) disappeared and then with excess methanol. The 
off white powder was dried in air to afford the final MINP (16 mg, 80%). 
Determination of Binding Constants by Fluorescence Titration. A typical procedure is as 
follows. A stock solution containing MINP5(1) (100 µM) was prepared in 50 mM Tris buffer 
(pH 7.4). Aliquots (1.0 µL) of the MINP stock solution were added to 2.00 mL of the solution 
of 1 in 50 mM Tris buffer (pH 7.4) (2 µM). After each addition, the sample was allowed to sit 
for 1 min at room temperature before the fluorescence spectrum was collected. The excitation 
wavelength (λex) was 350 nm. The excitation slit width was 10 nm, and the emission slit width 
was 10 nm. The binding constant was obtained by nonlinear least squares curve fitting of the 
fluorescence intensity at 448 nm to a 1:1 binding isotherm. 
Determination of Binding Constants by ITC. The determination of binding constants by 
ITC followed standard procedures.53-55 In general, a solution of an appropriate guest in in 50 
mM Tris buffer (pH 7.4) was injected in equal steps into 1.43 mL of the corresponding MINP 
in the same solution. The top panel shows the raw calorimetric data. The area under each peak 
represents the amount of heat generated at each ejection and is plotted against the molar ratio 
of the MINP to the guest. The smooth solid line is the best fit of the experimental data to the 
sequential binding of N binding site on the MINP. The heat of dilution for the guest, obtained 
by titration carried out beyond the saturation point, was subtracted from the heat released during 







Routine 1H and 13C NMR spectra were recorded on a Bruker DRX-400, on a Bruker AV II 600 
or on a Varian VXR-400 spectrometer.  ESI-MS mass was recorded on Shimadzu LCMS-2010 
mass spectrometer.  Dynamic light scattering (DLS) data were recorded at 25 °C using PDDLS/ 
CoolBatch 90T with PD2000DLS instrument.  Isothermal titration calorimetry (ITC) was 
performed using a MicroCal VP-ITC Microcalorimeter with Origin 7 software and 
VPViewer2000 (GE Healthcare, Northampton, MA). 
 






Figure 2S. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP5(1) 
after purification.  
 
Figure 3S. The correlation curve and the distribution of the molecular weight for 
MINP(glucose) from the DLS. The PRECISION DECONVOLVE program assumes the 
intensity of scattering is proportional to the mass of the particle squared. If each unit of building 
block for the MINP(glucose) is assumed to contain one molecule of compound 5 (MW = 520 
g/mol), 1.2 molecules of compound 6 (MW = 172 g/mol), one molecule of DVB (MW = 130 
g/mol), and 0.8 molecules of compound 7 (MW = 264 g/mol), the molecular weight of 








Figure 4S. 1H NMR spectra of (a) 8 in CDCl3, (b) alkynyl-SCM in D2O, and (c) MINP8(1) in 
D2O. 
 
Figure 5S. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP8(1) 






Figure 6S. The correlation curve and the distribution of the molecular weight for 
MINP(glucose) from the DLS. The PRECISION DECONVOLVE program assumes the 
intensity of scattering is proportional to the mass of the particle squared. If each unit of building 
block for the MINP(glucose) is assumed to contain one molecule of compound 8 (MW = 465 
g/mol), 1.2 molecules of compound 6 (MW = 172 g/mol), one molecule of DVB (MW = 130 
g/mol), and 0.8 molecules of compound 7 (MW = 264 g/mol), the molecular weight of 






Figure 7S. (a) Emission spectra of compound 1 (2.0 μM) upon the addition of different 
concentrations of MINP5(1) (0 equiv FM 9) in 50 mM Tris buffer (pH = 7.4). (b) Nonlinear 
least squares fitting of the emission intensity of compound 1 at 448 nm to a 1:1 binding isotherm. 
The data correspond to entry 1 in Table 1. 
   
Figure 8S. (a) Emission spectra of compound 1 (2.0 μM) upon the addition of different 
concentrations of MINP5(1) (1 equiv FM 9) in 50 mM Tris buffer (pH = 7.4). (b) Nonlinear 
least squares fitting of the emission intensity of compound 1 at 448 nm to a 1:1 binding isotherm. 





Figure 9S. (a) Emission spectra of compound 1 (2.0 μM) upon the addition of different 
concentrations of MINP5(1) (3 equiv FM 9) in 50 mM Tris buffer (pH = 7.4). (b) Nonlinear 
least squares fitting of the emission intensity of compound 1 at 448 nm to a 1:1 binding isotherm. 
The data correspond to entry 4 in Table 1. 
 
Figure 10S. (a) Emission spectra of compound 2 (2.0 μM) upon the addition of different 
concentrations of MINP5(1) (2 equiv FM 9) in 50 mM Tris buffer (pH = 7.4). (b) Nonlinear 
least squares fitting of the emission intensity of compound 2 at 460 nm to a 1:1 binding isotherm. 











Figure 11S. ITC titration curves obtained at 298 K for the titration of 10 μM of (a) MINP5(1) with 
0 equiv FM 9, (b) MINP5(1) with 1 equiv FM 9 (1:1), and (c) MINP5(1) with 3 equiv  FM 9 (1:3)  
by compound 1 (0.2 mM) in 50 mM Tris buffer (pH = 7.4). The data correspond to entries 1, 2, 4 







Figure 12S. ITC titration curves obtained at 298 K for the titration of 10 μM of MINP8(1) with 2 
equiv FM 9 (1:2) by compound 1 (0.2 mM) in 50 mM Tris buffer (pH = 7.4). The data correspond 
to entries 5 in Table 1.  













































































































































































Figure 13S. ITC titration curves obtained at 298 K for the titration of 10 μM of MINP1(2) with 2 
equiv FM 9 (1:2) by compound 2 (0.2 mM), compound 3 (0.2 mM), and compound 4 (0.2 mM) in 
















































































































































Figure 14S. ITC titration curves obtained at 298 K for the titration of 10 μM of MINP5(2) with 2 
equiv FM 9 (1:2) by compound 1 (0.2 mM), compound 2 (0.2 mM), compound 3 (0.2 mM), and 
compound 4 (0.2 mM) in 50 mM Tris buffer (pH = 7.4). The data correspond to entries 9, 10, 11, 
12 in Table 1. 
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ABSTRACT. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used over-the-
counter drugs and their uncontrolled disposal is a significant environmental concern. Although 
their fluorescent sensing is a desirable method of detection for its sensitivity and simplicity, the 
structural similarity of the drugs makes the design of selective sensors highly challenging. A 
thiourea-based fluorescent functional monomer was identified in this work to enable highly 
efficient synthesis of molecularly imprinted nanoparticle (MINP) sensors for NSAIDs such as 
Indomethacin or Tolmetin. Micromolar binding affinities were obtained in aqueous solution, 
with binding selectivities comparable to those reported for polyclonal antibodies. The detection 
limit was ~50 ng/mL in aqueous solution, and common carboxylic acids such as acetic acid, 
benzoic acid, and citric acid showed negligible interference.        
Introduction 
Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most commonly administered over-
the-counter drugs to reduce pain, decrease fever, and control inflammation.1 Due to their 
potential effects on different organisms, their wide usage and uncontrolled disposal are a 




in soil, rate of degradation varies greatly depending on the types of soil and other environmental 
conditions.4 
The important biological activity of NSAIDs and their environmental risks have motivated 
many researchers to develop sensitive methods for their detection and monitoring. Traditional 
analyses include electrophoresis5 and liquid chromatography–mass spectrometry6 but the 
sophisticated instruments utilized are inconvenient for rapid in-field monitoring. Recognition-
based fluorescent sensing is a method of choice for its simplicity, high sensitivity, and ease of 
operation.7-11 However, NSAIDs have very similar structures, with a carboxylic acid on a 
similarly sized hydrophobic aromatic moiety (Chart 1). The structural similarity represents a 
difficult challenge in the selective detection of these drugs by fluorescence,12-14 and traditional 
macrocyclic supramolecular hosts such as cyclodextrins tend to bind  NSAIDs 
nondisciminately.15 The difficulty prompted researchers to explore alternative formats of 
sensing, such as arrays of sensors, which showed good promise.16 Other choices include 
enzyme-linked immunosorbent assays (ELISA),17,18 but the structural similarity even 
challenges antibodies which are known for their highly specific binding.17  
 




One way to prepare a receptor for a target analyte is through molecular imprinting.19,20  The 
technique uses the analyte (or a surrogate) as the template and, through templated 
polymerization, creates analyte-complementary binding sites in a highly cross-linked polymer 
network. Molecularly imprinted polymers (MIPs) have been referred to as “plastic antibodies” 
and found numerous  applications.21-30 Indeed, MIPs generated for NSAIDs displayed selective 
adoption of these drugs,31-34 but their conversion into selective fluorescent sensors is hampered 
by the insolubility, heterogeneous distribution of binding sites, and other challenges associated 
with traditional MIPs.  
Our group developed a method of molecular imprinting in doubly cross-linked micelles 
(Scheme 1).35 The method involves first surface-crosslinking of micelle of 6 with diazide 7 
using the click reaction and then core-cross-linking with divinylbenzene (DVB) using free-
radical polymerization. The cross-linked micelles are also functionalized with a layer of 
hydrophilic ligand (i.e., 8) for increased hydrophilicity and facile purification. The method can 
be applied to a wide range of small-molecule drugs,35,36 peptides,37 and carbohydrates.38,39 The 
resulting molecularly imprinted nanoparticles (MINPs) showed strong abilities to distinguish 
closely related structures including leucine and isoleucine in peptides37 and inversion of a single 
hydroxyl in oligosaccharides.38,39 MINPs are ~5 nm in diameter, and mimic proteins in their 
nanosize, hydrophilic exterior, and hydrophobic core. The number of binding sites per MINP 
can be conveniently controlled by the surfactant/template ratio.  
In this work, we report the design and synthesis of several fluorescent functional monomers 
(FMs) for selective NSAID detection. Structure of fluorophore was found to impact the sensing 
strongly, with minor variation in substitution pattern totally changing the behavior of the 




derivative, allowed highly selective binding of the drugs. Strong binding between the thiourea 
group of the FM and the carboxylic acid of NSAID helped the fluorescent probe reside near the 
imprinted binding site so that the guest binding was readily detected by fluorescent change. 
 
Scheme 1. Preparation of MINP by surface–core double cross-linking of template-containing 




Results and Discussion 
Design and Synthesis of Fluorescent Functional Monomers to Bind Carboxylates. 
Molecular imprinting can be very effective at creating template-specific binding sites in a 
polymer network. To create a fluorescent sensor for NSAIDs, however, we need to not only 
have a strong and selective binding for the drug but also convert the binding into an easy-to-
detect fluorescent signal.31-34,36 Our strategy is to employ a functional monomer containing an 
environmentally sensitive fluorophore and a strong carboxylate-binding moiety in close 
proximity.40 In addition, highly specific, strong binding must exist between the FM and the 
NSAID drug so that the fluorophore will stay near the imprinted site. 
Compounds 9–12 fit the above criteria. The FMs generally have a push–pull fluorophore 
known to be highly sensitive to its microenvironment, based on either the amino-
nitrobenzoxadiazole (amino-NBD) or aminonaphalenesulfonate (ANS) framework. All 
compounds have at least one polymerizable vinyl group from a methacrylate, methacrylamide, 
or styrene. All have a reasonable level of hydrophobicity for their facile incorporation into of 
micelle for the MINP preparation. FM 9 has a guanidinium cation to bind a carboxylate through 
a hydrogen-bond-reinforced salt bridge. FMs 10–12 employ either a urea or thiourea group to 
form double hydrogen bonds with a carboxylate. In all cases, the carboxylate-binding moiety 
is adjacent to the fluorophore, in the hope that the binding would trigger a noticeable change in 
the latter’s emission. Although hydrogen-bonds are weakened by strong solvent competition in 
aqueous solution, they are known to become much stronger in the hydrophobic core of 





Table 1. Binding constants between carboxylate guests and FM 9–12 in CTAB solution.a 
entry FM guest Ka (10
3 M-1) 
1 9 sodium acetate 
-b 
2 9 sodium butyrate 
-b 
3 9 sodium octanoate 
-b 
4 10 sodium acetate 
0.016 ± 0.3 
5 10 sodium butyrate 
0.34 ± 0.05 
6 10 sodium octanoate 
3.01 ± 0.26 
7 11 sodium acetate 
0.17 ± 0.06 
8 11 sodium butyrate 
0.49 ± 0.04 
9 11 sodium octanoate 1.51 ± 0.14 
10 12 sodium acetate 0.18 ± 0.06 
11 12 sodium butyrate 0.78 ± 0.23 
12 12 sodium octanoate 5.18 ± 0.12 
a The binding constants were obtained from fluorescence titrations performed in duplicates in 
2 mM CTAB solution. [FM] = 2.0 μM. b Binding constant could not be obtained because of 





To test the suitability of these compounds as fluorescent FMs for NSAID sensing, we first 
studied their binding of simple carboxylates in a micellar solution of CTAB (cetyl 
trimethylammonium bromide) (Table 1). The cationic surfactant is commercially available and 
mimics 6 without any concerns of polymerization. We evaluated the binding with sodium 
acetate, butyrate, and octanoate, respectively, with the expectation that a more hydrophobic 
carboxylate would have a stronger driving force to enter the micelle and display an enhanced 
binding. As mentioned above, a successful fluorescent sensor could only be obtained if the 
fluorescent FM stayed near the template during polymerization/cross-linking. A strong binding 
between the FM and the template in the aqueous micellar solution thus is a prerequisite. 
 
In our hands, the emission of 9 in CTAB solution was very weak and showed little response 
to the addition of the carboxylate salts. Meanwhile, even though the emission of 10 was 
quenched strongly by the carboxylates and good binding properties were obtained (Table 1, 
entries 4–6), the solubility of the molecule in micellar solutions, whether of CTAB or 6, was 
very low. The poor solubility made 10 unsuitable as a FM because our previous studies showed 
that MINP prepared with 6 as the cross-linkable surfactant contained ~50 cross-linked 
surfactants. For typical MINPs, we want to reach at least 1:50 for the FM/surfactant ratio, so 
that the final MINP will have an average of one binding site per nanoparticle.35 
We suspected that the poor solubility of 10 was caused by strong intermolecular interactions 
among the molecules as a result of the neutral, relatively rigid structure.  In addition, a urea 
group has an excellent hydrogen-bond acceptor (carbonyl) and two good hydrogen-bond donors 
(NH), making self-association of the FM very strong. In view of these challenges, we designed 




a thiourea instead. Without a strong hydrogen-bond acceptor, thioureas tend to self-associate 
much weakly than ureas.  
Both 11 and 12, to our delight, were easily incorporated into micelles and were actually 
soluble in water themselves. In addition, they both bound the carboxylates, exhibiting larger 
bonding constants (Ka) with an increase in the hydrocarbon chain length of the guest (Table 1, 
entries 7–12). The submillimolar binding affinities suggest, under typical MINP preparation 
conditions (i.e., 10 mM of 6 and 0.2 mM of FM), a substantial amount of the carboxylate guest 
will be complexed with the FM.44 Upon further screening, compound 11 was rejected because 
its resulting MINP displayed very little fluorescence response to the template. Fortunately, 
compound 12, with a simple change of substitution pattern from 2,6- to 1,5 on the naphthalene 
ring, showed strong binding for hydrophobic carboxylates in the CTAB micelle (Table 1, 
entries 10–12) and the resulting MINP also worked well (vide infra). 
Fluorescent MINPs for Indomethacin (1). Our initial NSAID target was Indomethacin (1). 
Not only is this drug commonly used to treat osteoarthritis and rheumatoid arthritis, the COX-
2 inhibitor has been used to construct fluorescent probes to target the Golgi apparatus of cancer 
cells.45 Preparation of MINP(1), i.e., MINP prepared with Indomethacin (1) as the template, 
follows previously reported procedures and is described in the Experimental Section. The 
surface- and core-cross-linking of the micelle was monitored by 1H NMR spectroscopy. The 
surface-cross-linking chemistry had been confirmed by mass spectrometry previously.46 The 
micelles underwent characteristic changes in size during the surface-cross-linking, surface-
functionalization, and core-cross-linking, and could be monitored by dynamic light scattering 




Figure 1a shows the emission spectra of 2.0 μM MINP(1) in 50 mM Tris buffer (pH = 7.4) 
upon the addition of 0–10 μM Indomethacin. The MINP was prepared with a 2:1 ratio of 
FM/template. The emission maximum (λem) for the MINP occurred at 414 nm. The number was 
significantly shifted to the blue than the value in CTAB solution, 430 nm (Figure S15). This is 
in agreement with the common behavior of ANS-based fluorophores that tend to emit at a 
shorter wavelength in a less polar environment.49 A CTAB micelle is highly dynamic. FM 12 
in the uncross-linked micelle thus had a much higher chance to be exposed to water than in the 
doubly cross-linked MINP.50  
 
 
Figure 1. (a) Emission spectra of MINP(1) in 50 mM Tris buffer (pH = 7.4) upon the addition 
of different concentrations of 1. The MINP was prepared with a 2:1 FM/template ratio. λex = 
310nm. [MINP(1)] = 2.0 μM. The concentration of MINP was calculated based on a M.W. of 
49300 g/mol determined by DLS. (b) Nonlinear least squares fitting of the emission intensity 
of MINP(1) at 414 nm to a 1:1 binding isotherm.  
The addition of 0–10 μM Indomethacin caused significant quenching of the MINP’s 




1b, the emission intensity at 414 nm fit nearly perfectly to a 1:1 binding isotherm, affording a 
binding constant of Ka = (1.68 ± 0.20) × 10
5 M-1. This value was substantially higher than those 
observed between FM 12 and octanoate in CTAB micelles (5.18 × 103 M-1). Although the two 
guests have a different hydrophobe, the nearly 30-times stronger binding in MINP suggests that 
an imprinted micelle did provide a better binding environment to the guest than the generic 
nonpolar core of a CTAB micelle.  
An important parameter to optimize is the ratio of FM/template in the MINP preparation. 
Too small an amount of the FM would leave many templates uncomplexed during cross-linking 
and polymerization. Although imprinted sites would form under such a situation, the binding 
pocket would not have a nearby fluorescent group to report the binding. Too large an amount 
of the FM during the MINP preparation, on the other hand, would incorporate many 
polymerized fluorophores in the MINPs without a nearby binding site for the guest. Neither 
situation is desirable. 
To identify the optimal FM/T ratio, we prepared MINPs with 1 as the template and 1, 2, and 
3 equivalents of FM 12. We then measured the Ka values for not only the template itself, but 
also two other NSAIDs, Tolmetin (2) and Ibuprofen (3). We wanted to the know the best FM/T 
ratio for both the binding affinity and selectivity.  
As shown by entries 1 and 4 of Table 2, the binding constant of MINP(1) for the template 
more than doubled from  79 × 103 to 168 × 103 M-1 when the FM/T ratio increased from 1:1 to 
2:1. However, a further increase of the FM in the preparation reversed the trend and afforded a 






Table 2. Binding constants of MINP(1) prepared with different FM/T ratios for NSAIDs and 
selected small-molecule acids.a  
 
entry FM/T ratio guest Ka (10
3 M-1) CRRb 
1 1:1 Indomethacin (1) 
79 ± 0.3 1 
2 1:1 Tolmetin (2) 
14 ± 2 0.18 
3 1:1 Ibuprofen (3) 
0.7 ± 0.3 0.01 
4 2:1 Indomethacin (1) 
168 ± 20 1 
5 2:1 Tolmetin (2) 
22 ± 3 0.13 
6 2:1 Ibuprofen (3) 1.1 ± 0.3 0.01 
7 2:1 Diclofenac (4) 
5.1 ± 0.5 0.03 
8 2:1 Ketoprofen (5) 
15 ± 0.1 0.12 
9 2:1 Mefenamic acid (6) 4.7 ± 0.6 0.03 
10 2:1 acetic acid 
0.3 ± 0.1 0.002 
11 2:1 butyric acid 
0.1 ± 0.1 0.0006 
12 2:1 benzoic acid 0.3 ± 0.2 0.002 
13 2:1 citric acid 0.2 ± 0.1 0.001 
14 3:1 Indomethacin (1) 120 ± 27 1 
15 3:1 Tolmetin (2) 25 ± 4 0.21 
16 3:1 Ibuprofen (3) 1.2 ± 0.1 0.01 
a The binding constants were obtained from fluorescence titrations performed in duplicates 
in 50 mM Tris buffer (pH = 7.4). λex = 310 nm. [MINP(1)] = 2.0 μM. 
b CRR is the cross-





similar trend, as measured by the cross-reactivity ratio (CRR), defined as the binding constant 
of  a guest relative to that of the template for a particular MINP. Among the two analogues 
studied, Tolmetin (2) is more similar to Indomethacin (1) than  Ibuprofen (3), in terms of both 
functionality and size. Indeed, the CRR for Tolmetin was 0.18, 0.13, and 0.21, respectively as 
the FM/T increased from 1 to 3. The absolute binding constant for Tolmetin was 14, 22, and 25 
× 103 M-1 for these MINPs (entries 2, 5, and 15). The data, thus, suggests that the 2:1 FM/T 
ratio gave the best selectivity for the template as a result of increasing the binding for the 
template more than it did for its structural analogue.      
For the best MINP(1), we also measured its binding constant for all the other NSAIDs shown 
in Chart 1, as well as several carboxylic acids (acetic acid, butyric acid, and citric acid). Among 
the structural analogues, Tolmetin (2) and Ketoprofen (5) showed the highest cross reactivity 
(CRR = 0.13 and 0.12, respectively). The other three NSAIDs (Ibuprofen, Diclofenac, and 
Mefenamic acid) showed very little binding (CRR = 0.01–0.03).  
Polyclonal antibodies have been generated and used in competitive ELISA assays for 
Indomethacin.51 Tolmetin gave about 0.09 corss reactivity in the assay, slightly better than our 
0.13. However, Dichlofenac displayed 0.09 cross-reactivity with the natural antibody but only 
0.03 in our case. Thus, the selectivity of our synthetic antibody compares very favorably overall 
with that of natural polyclonal antibodies which require live animal and a much longter time to 
produce. As cross-linked polymeric nanoparticles, MINPs also have the benefit of tolerating 
high temperature,35,52 organic solvent,52 extreme pH,53. 
For MINP binding in water, hydrophobic interactions are known to contribute strongly.35 
Although these interactions are nonspecific in nature, complementarity can come from 




strong carboxyl-binding thiourea in our MINP, complementarity in hydrogen bonds is also 
expected to be important. 
Figure 2a gives a schematic representation of the binding of the template (Indomethacin) by 
MINP(1). Despite the simplistic comparison, the model does help to explain the binding data 
given in Table 2. Guests 2 and 5, for example, gave the highest cross-reactivity (0.12–0.13) in 
binding among the five NSAID analogues. For comparison purposes, we colored the original 
template (1) red, as well as the substructures in the analogous drugs that resemble the original 
template. Tolmetin (2), as shown in Figure 2b, contains a pyrrole ring bonded to the α-carbon 
of the carboxyl. Although the methyl group is next to the pyrrole nitrogen in 1 and on the 
pyrrole nitrogen in 2, the overall shape of the five-membered ring (including the methyl) and 
the para-substituted benzoyl group in the two compounds are very similar. The great structural 
resemblance suggests that, no matter how perfectly the binding site will be created for 1, it will 
always bind 2, albeit with a lower affinity due to the incomplete filling of the binding site. 
 The other guest that showed a high CRR value was Ketoprofen (5), shown in Figure 2e. The 
most obvious mismatch between the molecule and the template is the extra methyl group on 
the α-carbon of the carboxyl, shown in black. Although a phenyl instead of a pyrrole is bonded 
to the α-carbon in 5, the meta-substituted benzoyl group was oriented similarly as that in 1. 
Thus, the overall similarity of Ketoprofen was quite high to the template, consistent with the 
0.12 CRR (Table 2, entry 8). 
The guests that fit most poorly in the imprinted site were 4 and 6 (Figure 2d,f). Their 
carboxylic acid is directly bonded to the phenyl ring, without a methylene in between as in the 




overall shape of these molecules very different from that of the template. Their weak binding, 
thus, was fully expected. 
 
 
Figure 2. Schematic representation of the binding of 1–6 inside the binding site of MINP(1).  
 
Ibuprofen (3) also displayed a very weak binding relative to the template, with a CRR of 
0.01 (Table 2, entries 5–9). Given the reasonable level of similarity between 3 and 5, we had 
not expected 3 to be so much worse a guest for MINP(1), since 5 was the best among the 
nonmatching NSAIDs. Nonetheless, there were several reasons that disfavored the binding of 
Ibuprofen: it contains an extra methyl on the α-carbon of the carboxyl; it is overall the smallest 




on the para carbon, with respect to the carboxylic acid. It is possible that there were just too 
many mismatches and together they tipped the balance. 
Finally, none of the other potentially interfering carboxylic acids showed any significant 
binding, including acetic acid, butyric acid, benzoic acid and citric acid (Table 2, entries 10–
13).        
Table 3. Binding constants of MINP(2) prepared with different FM/T ratios for NSAIDs and selected 
small-molecule acids.a  
Entry guest Ka (10
3 M-1) CRRb 
1 Indomethacin (1) 8.9 ± 1.8 0.11 
2 Tolmetin (2) 84 ± 17 1 
3 Ibuprofen (3) 1.3 ± 0.3 0.02 
4 Diclofenac (4) 5.4 ± 1.1 0.06 
5 Ketoprofen (5) 19 ± 3 0.23 
6 Mefenamic acid (6) 4.3 ± 0.5 0.05 
7 acetic acid 0.3 ± 0.1 0.004 
8 butyric acid 0.7 ± 0.2 0.008 
9 benzoic acid 1.3 ± 0.4 0.02 
10 citric acid 0.6 ± 0.1 0.007 
a The binding constants were obtained from fluorescence titrations performed in duplicates in 
in 50 mM Tris buffer (pH = 7.4). λex = 310 nm. [MINP(2)] = 2.0 μM. 
b CRR is the cross-






To demonstrate the generality of our method, we also prepared MINP with Tolmetin (2) as 
the template. Table 2 summarizes its binding constants obtained for various guests. Consistent 
with successful imprinting, the MINP bound its template most strongly among the analogues. 
The binding constant (84 × 103 M-1) was about half of that observed for 1 by MINP(1). This 
trend was reasonable, given the larger size of Indomethacin. It is well known that the strength 
of hydrophobic interactions is directly proportional to the area of hydrophobic surface being 
buried upon binding.54 As long as the imprinted sites match their templates well, a larger 
template will have a stronger driving force to enter its imprinted site than a small template (to 
its own).  
Table 1 shows that NSAID 2 and 5 showed the strongest cross-reactivities in the binding of 
MINP(1), suggesting these two drugs were more similar to each other than other NSAIDs 
examined in our work. Table 3 shows that, when 2 was used as the template, the drug that 
showed the strongest cross-reactivity was 5, with a CRR of 0.23. Thus, both binding studies 
were able to classify NSAIDs according to their structural similarity. 
The low CRR values for 4 and 6 are expected, given the ortho substitution and the direct 
connection of the carboxylic acid to the first phenyl ring (Table 3, entries 4 and 6). The weak 
binding of 3 was not surprising either (entry 3), considering the para substitution and the 
mismatched size. None of the other, non-NSAID carboxylic acids showed significant binding 
(entries 7–10)—also an expected result. 
The most surprising result in Table 3 was the relative large cross-reactivity of Indomethacin 
(1) toward MINP(2), with CRR = 0.11 (Table 3, entry 1). We have found in multiple examples 




guests can be bound by a larger imprinted site, with reduced affinity.35,37,55 From this stand 
point, a weaker binding of 2 by MINP(1) was reasonable (Table 2, entry 2) but a weaker and 
yet significant binding of 1 by the MINP made with the much smaller template (2) did not make 
sense. 
A plausible reason for the above abnormity comes from the depth of the imprinted binding 
site, which is formed through double cross-linking of the micelle (Scheme 1). However, the 
surface cross-linker used in the MINP preparation was diazide 2, which has four methylene 
groups between the two azides. There are, therefore, many rotatable bonds in between two 
cross-linked ammonium headgroups, making the surface-cross-linking density quite low. The 
core-cross-linking, on the other hand, happens through radical polymerization of the 
methacrylate with nearly 50 DVB molecules in each micelle, and thus should have a 
considerably higher density. The template–FM complex formed by 12 with either 1 or 2 are 
quite polar, with an anionic sulfonate and another anionic carboxylate. Because polar and, 
especially, ionic groups have a strong need to be solvated by water on the surface of the micelle, 
the template–FM complex should be located near the surfactant/water interface and the 
imprinted site from the complex will also be quite close to the surface of the micelle. If this 
assumption is true, a higher plasticity of the binding site would be anticipated, due to the low 
surface-cross-linking density mentioned above. Nevertheless, both MINP(1) and MINP(2) 
displayed strong selectivities among most NSAIDs, especially toward 4 and 6. Thus, it seems, 
even for a relatively flexible network, the imprinted site still has a good memory of the original 





Fluorescent Sensing of NSAIDs. Figure 3 shows the change of fluorescence intensity of 
MINP(1) by 10 µM of different acids in 50 mM Tris buffer (blue columns). The red columns 
are the responses of the nonimprinted nanoparticle (NINP), prepared with FM 12 but without 
any template. The imprinting effect was very strong in our MINP, as shown by the large 
difference in the responses of the imprinted versus nonimprinted sensor. The other acids all had 
a smaller effect on the emission intensity of MINP(1) and the responses seemed to largely 
follow the binding affinities. Table 2, for example, shows that Tolmetin (2) and Ketoprofen (5) 
gave the highest CRR for MINP(1) among the non-templating NSAIDs. In Figure 3, these two 
drugs also showed the largest responses, after the template itself. Fluorescent sensing was also 
performed with MINP(2). As shown by Figure 4, excellent selectivity was observed again for 





































Figure 3. Change of fluorescence emission intensity of MINP(1) caused by different carboxylic 











































Figure 3. Change of fluorescence emission intensity of MINP(2) caused by different carboxylic 
acids in 50 mM Tris buffer (pH = 7.4). [MINP(1)] = 2.0 µM. [Acid] = 10 µM. λex = 310 nm. 
The strong binding of MINP(1) and MINP(2) for their targeted drugs suggestion the 
detection for Indomethacin and Tolmetin should be quite sensitive. To calculate the detection 
limit, we measured the emission intensity of 2.0 μM MINP(1) in the presence of 1–5  μM 
Indomethacin in 50 mM Tris buffer. The detection limit, calculated from 3δ/slope, was about 
140 nM  (Figure S41). The concentration translates to 50 ng/mL, a little over three times of 
what was reported for the antibody-based ELISA assay (15 ng/mL).51 For Tolmetin, our 
detection limit was 200 nM or 51 ng/mL by MINP(2) (Figure S42). 
Conclusions 
The high structural similarity among NSAIDs makes it difficult even for natural antibodies 
to distinguish the drugs. The molecularly imprinted cross-linked micelles, nonetheless, 




functional monomer is highly important, with compound 12 being the only one useful among 
the four synthesized. Once the correct FM and all the other ingredients of MINPs are available, 
MINP-based fluorescent sensors can be prepared and purified in less than 2 days for different 
drugs. The binding studies showed that these sensors could bind the desired drug selectively 
among analogues and also classified the analogues based on their structural similarity to the 
original template. Fluorescent sensing could easily detect 100–200 nM or ~50 ng/mL of the 
drugs in water. 
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Experimental Section 
General Method. Routine 1H and 13C NMR spectra were recorded on a 400 and 600 MHz 
NMR spectrometer. ESI-MS mass was recorded on Shimadzu LCMS-2010 mass spectrometer. 
Dynamic light scattering (DLS) data were recorded at 25 °C using PDDLS/CoolBatch 90T with 
PD2000DLS instrument.  Isothermal titration calorimetry (ITC) was performed using a 
MicroCal VP-ITC Microcalorimeter with Origin 7 software and VPViewer2000 (GE 
Healthcare, Northampton, MA). Syntheses of compounds 6–8 were reported previously.35 
Syntheses of the fluorescent functional monomers (9–12) are reported in the Supporting 
Information (SI). 
Preparation of MINPs and NINPs. A typical procedure is as follows.35 To a micellar 
solution of compound 6 (10.2 mg, 0.02 mmol) in H2O (2.0 mL), divinylbenzene (DVB, 2.8 μL, 
0.02 mmol), compound 1 in H2O (10 μL of a solution of 18.5 mg/mL, 0.0004 mmol), and 2,2-




mmol) were added. The mixture was subjected to ultrasonication for 10 min before compound 
7 (4.13 mg, 0.024 mmol), CuCl2 (10 μL of a 6.7 mg/mL solution in H2O, 0.0005 mmol), and 
sodium ascorbate (10 μL of a 99 mg/mL solution in H2O, 0.005 mmol) were added. After the 
reaction mixture was stirred slowly at room temperature for 12 h, compound 8 (10.6 mg, 0.04 
mmol), CuCl2 (10 μL of a 6.7 mg/mL solution in H2O, 0.0005 mmol l), and sodium ascorbate 
(10 μL of a 99 mg/mL solution in H2O, 0.005 mmol) were added. After being stirred for another 
6 h at room temperature, the reaction mixture was transferred to a glass vial, purged with 
nitrogen for 15 min, sealed with a rubber stopper, and irradiated in a Rayonet reactor for 12 h. 
1H NMR spectroscopy was used to monitor the progress of reaction. The reaction mixture was 
poured into acetone (8 mL). The precipitate was collected by centrifugation and washed with a 
mixture of acetone/water (5 mL/1 mL) three times. The crude produce was washed by 
methanol/acetic acid (5 mL/0.1 mL) three times until the emission peak at 448 nm (for the 
dansyl) disappeared and then with excess methanol. The off white powder was dried in air to 
afford the final MINPs (16 mg, 80%). NINPs were prepared following similar procedures 
except no template was used. 
Determination of Binding Constants by Fluorescence Titration. A typical procedure is as 
follows. A stock solution of the acid (200 µM) was prepared in 50 mM Tris buffer (pH = 7.4). 
Aliquots (2 µL) of the acid stock solution were added to 2.00 mL of MINP(1) solution (2.0 µM) 
in the same buffer. After each addition, the sample was allowed to sit for 1 min at room 
temperature before the fluorescence spectrum was collected. The excitation wavelength (λex) 
was 370 nm. The excitation slit width was 10 nm, and the emission slit width was 10 nm. The 
binding constant was obtained by nonlinear least squares fitting of the emission intensity at 420 





Routine 1H and 13C NMR spectra were recorded on a Bruker DRX-400, on a Bruker AV II 600 
or on a Varian VXR-400 spectrometer.  ESI-MS mass was recorded on Shimadzu LCMS-2010 
mass spectrometer.  Dynamic light scattering (DLS) data were recorded at 25 °C using PDDLS/ 
CoolBatch 90T with PD2000DLS instrument.  Isothermal titration calorimetry (ITC) was 
performed using a MicroCal VP-ITC Microcalorimeter with Origin 7 software and 
VPViewer2000 (GE Healthcare, Northampton, MA). 
 
Scheme S1. Syntheses of fluorescent functional monomer 9 
 





Scheme S3. Syntheses of fluorescent functional monomer 11. 
 
 
Scheme S4. Syntheses of fluorescent functional monomer 12. 
 
Syntheses 
Compound 14. To a solution of 5-aminonaphthalene-1-sulfonic acid (0.223 g, 1 mmol) in 
anhydrous DMF(10 mL) was added 1,3-bis(tert-butoxycarbonyl)-2-methylthiopseudourea 
(0.75 g, 2.5 mmol), triethylamine (0.61 g, 6 mmol) and mercury chloride (0.68 g, 2.5 mmol). 
The suspension was stirred at room temperature overnight. The reaction mixture was diluted 
with CH2Cl2. The organic phase was washed with Na2CO3 solution, filtered through a pad of 
Celite, washed with water 3 times, dried over anhydrous Na2SO4, and concentrated by rotary 
evaporation. The residue was purified by column chromatography over silica gel using 10:1 
CH2Cl2/MeOH as the eluent to give a light brown powder (0.39 g, 70%). 
1H NMR (400 MHz, 




(m, 2H), 3.06 (q, J = 7.3 Hz, 6H), 1.64–1.22 (m, 18H), 1.22–1.12 (m, 9H). 13C NMR (151 MHz, 
CD3OD, δ) 163.4, 157.8, 141.7, 129.8, 129.6, 126.0, 125.7, 125.4, 125.0, 124.8, 124.8, 123.7, 
53.8, 46.5, 27.3, 8.0. HRMS (ESI/QTOF) m/z: calcd for C21H28N3O7S
+ [M + H – Et3N]
+ 
466.1642, found 466.1652.  
 
Compound 15. A catalytic amount of DMF was added to a solution of compound 14 (57 mg, 
0.1 mmol) in 2 mL of thionyl chloride. After the mixture was stirred at room temperature for 3 
h, thionyl chloride was removed by rotary evaporation. The residue was dissolved in 2 mL of 
anhydrous dichloromethane, followed by the addition of triethylamine (50 mg, 0.5 mmol). The 
above mixture was slowly added to a solution of ethylenediamine (60 mg, 1 mmol) 
dichloromethane at 0 °C. The ice bath was removed after 20 min and stirring was continued at 
room temperature for 3 h. After the solvent was removed by rotary evaporation, the residue 
was purified by column chromatography over silica gel using 10:1 CH2Cl2/MeOH as the eluent 
to give a light brown powder (28 mg, 55%). 1H NMR (400 MHz, CD3OD, δ) 8.64 (d, J = 8.5 
Hz, 1H), 8.29 (m, 2H), 7.73 (m, 3H), 3.02 (t, J = 5.9 Hz, 2H), 2.94 (t, J = 5.9 Hz, 2H), 1.50 (1s, 
18H). 13C NMR (151 MHz, CD3OD, δ) 162.5, 157.2, 135.0, 130.3, 129.5, 129.3, 128.8, 128.2, 
127.7, 127.6, 124.7, 123.3, 54.0, 40.7, 39.7, 27.1. HRMS (ESI/QTOF) m/z: calcd for 
C23H34N5O6S
+ [M + H]+ 508.2224, found 508.2222.  
 
Compound 16. Methacryloyl chloride (22 mg, 2.2 mmol) in anhydrous dichloromethane (5 
mL) was added slowly to a mixture of compound 15 (51 mg, 1 mmol) and triethylamine (30 
mg 3 mmol) in anhydrous dichloromethane (5 mL)  at 0 °C. After the mixture was stirred for 3 




chromatography over silica gel using 4:1 hexane/ethyl acetate as the eluent to give a light brown 
powder (40 mg, 62%). 1H NMR (600 MHz, CD3OD, δ) 8.46–8.35 (m, 2H), 8.29 (s, 1H), 7.90 
(s, 1H), 7.76 (m, 2H), 5.83 (s, 1H), 5.46 (s, 1H), 5.34 (s, 1H), 5.26 (s, 1H), 4.20 (s, 2H), 3.60 
(s, 2H), 2.02 (s, 3H), 1.74 (s, 3H), 1.52 (s, 18H). 13C NMR (151 MHz, CD3OD, δ) 175.2, 172.0, 
171.5, 170.0, 139.9, 139.7, 133.9, 133.89, 133.88, 133.6, 132.6, 128.6, 128.3, 124.5, 124.4, 
120.3, 119.6, 60.2, 45.4, 38.8, 27.0, 18.2, 17.4. HRMS (ESI/QTOF) m/z: calcd for 
C31H42N5O8S
+ [M + H]+ 644.2749, found 644.2762.  
 
Compound 9. Compound 16 (64 mg, 1 mmol) was dissolved in 4 mL of dichloromethane, 
followed with the addition of 4 mL of trifluoroacetic acid.  The mixture was stirred for 3 h. 
After the solvent was removed by rotary evaporation, the residue was purified by column 
chromatography over silica gel using 5:1 CH2Cl2/MeOH as the eluent. The material obtained 
was dissolved in methanol (5 mL), followed by the addition of sodium chloride (290 mg, 5 
mmol) in water (5 mL). After being stirred for 6 h, the mixture was diluted with CH2Cl2 (10 
mL). The organic layer was washed with water (2 × 30 mL), dried over sodium sulfate, and 
concentrated by rotary evaporation to give a light brown powder (39 mg, 81%). 1H NMR (400 
MHz, CD3OD, δ) 8.47 (d, J = 8.6 Hz, 2H), 8.39 (d, J = 8.5 Hz, 1H), 7.87–7.75 (m, 2H), 7.68 
(d, J = 7.5, 1H), 5.74 (t, J = 1.1 Hz, 1H), 5.39 (m, 1H), 5.30 (d, J = 1.8 Hz, 1H), 5.19 (d, J = 
1.3 Hz, 1H), 4.15 (t, J = 5.9 Hz, 2H), 3.51 (m, 2H), 1.94 (t, J = 1.2 Hz, 3H), 1.71 (d, J = 1.2 
Hz, 3H). 13C NMR (100 MHz, CD3OD, δ) 171.9, 170.1, 157.6, 139.6, 134.4, 133.0, 131.8, 
131.3, 129.2, 129.1, 128.4, 127.02, 126.99, 125.4, 125.4, 124.3, 120.2, 45.5, 38.7, 18.2, 17.4. 
HRMS (ESI/QTOF) m/z: calcd for C21H26N5O4S





Compound 10. Compound 17 (90 mg, 0.5 mmol) and N,N-diisopropylethylamine (DIPEA, 97 
mg) were added to a solution of 4-vinylphenyl isocyanate (73 mg, 0.5 mmol) in dry THF (10 
mL). After the reaction mixture was stirred overnight under nitrogen, the solvent was removed 
by rotary evaporation. The residue was purified by column chromatography over silica gel 
using 4:1 dichloromethane/methanol as the eluent to give a red powder (88 mg, 54%). 1H NMR 
(600 MHz, acetone-d6) δ 8.76 (d, J = 8.4 Hz, 1H), 8.42 (d, J = 8.5 Hz, 1H), 7.62 (d, J = 8.1 Hz, 
2H), 7.50 (d, J = 8.2 Hz, 2H), 6.84–6.67 (m, 1H), 5.77 (d, J = 17.6 Hz, 1H), 5.20 (d, J = 10.9 
Hz, 1H). 13C NMR (101 MHz, acetone-d6) δ 150.8, 145.5, 143.5, 136.3, 136.0, 135.6, 133.0, 
126.8, 126.6, 118.9, 118.3, 112.1, HRMS (ESI/QTOF) m/z: calcd for C15H10N5O4 [M - H]
- 
324.0738, found 324.0741.  
 
Compound 11. Compound 18 (18 mg, 0.11 mmol) was added slowly to a stirred solution of 6-
aminonaphthalene-2-sulfonic acid (23 mg, 0.1 mmol) and DIPEA (20 mg, 0.15 mmol) in DMF 
(5 mL). The reaction mixture was heated to 70 °C for 24 h. After the mixture was cooled to 
room temperature, water (15 mL) was added. The mixture was extracted with ether (3 × 10 
mL). The combined organic solution was concentrated by rotary evaporation and the residue 
was mixed with sodium dodecyl sulfate (56 mg) in water (5 mL). After the micellar solution 
was stirred at room temperature for 2 h, it was extracted with dichloromethane (3 × 10 mL). 
The combined organic solution was dried over sodium sulfate and concentrated by rotary 
evaporation. The residue was purified by column chromatography over silica gel using 4:1 
dichloromethane/methanol as the eluent to give a white powder (22 mg, 52%). 1H NMR (600 
MHz, D2O, δ) 8.23 (s, 1H), 7.91 (d, J = 8.7 Hz, 1H), 7.82 (d, J = 8.6 Hz, 1H), 7.80 – 7.71 (m, 




1.77 (s, 3H). 13C NMR (126 MHz, D2O, δ) 179.7, 169.5, 139.7, 135.9, 135.6, 134.3, 130.7, 
130.5, 128.8, 127.1, 125.3, 125.1, 123.0, 122. 7, 63.2, 43.4, 17.3. HRMS (ESI/QTOF) calcd for 
C17H19N2O5S2 [M+H]
+ 395.0730, found 395.0738. 
 
Compound 12. Compound 18 (18 mg, 0.11 mmol) was added slowly to a stirred solution of 6-
aminonaphthalene-2-sulfonic acid (23 mg, 0.1 mmol) and DIPEA (20 mg, 0.15 mmol) in DMF 
(5 mL). The reaction mixture was heated to 70 °C for 24 h. After the mixture was cooled to 
room temperature, water (15 mL) was added. The mixture was extracted with ether (3 × 10 
mL). The combined organic solution was concentrated by rotary evaporation and the residue 
was mixed with sodium dodecyl sulfate (56 mg) in water (5 mL). After the micellar solution 
was stirred at room temperature for 2 h, it was extracted with dichloromethane (3 × 10 mL). 
The combined organic solution was dried over sodium sulfate and concentrated by rotary 
evaporation. The residue was purified by column chromatography over silica gel using 4:1 
dichloromethane/methanol as the eluent to give a white powder (26 mg, 61%). 1H NMR (400 
MHz, CD3OD, δ) 8.84 (d, J = 8.8 Hz, 1H), 8.14 (d, J = 7.2 Hz, 1H), 8.00 (d, J = 8.5 Hz, 1H), 
7.56 (dd, J = 8.7, 7.3 Hz, 1H), 7.51–7.37 (m, 2H), 5.88 (s, 1H), 5.49 (s, 1H), 4.18 (t, J = 5.4 Hz, 
2H), 3.79 (t, J = 5.4 Hz, 2H), 1.77 (s, 3H). 13C NMR (100 MHz, CD3OD, δ) 186.2, 171.2, 145.1, 
139.9, 135.1, 134.1, 131.0, 130.0, 129.9, 129.7, 129.6, 129.2, 128.8, 111.0, 66.7, 47.3, 20.9. 
HRMS (ESI/QTOF) m/z: calcd for C17H17N2O5S2 [M - Na]








Figure S1. 1H NMR for MINP(1). 1H NMR spectra of (a) 6 in CDCl3, (b) alkynyl-SCM in 
D2O, and (c) MINP(1) in D2O. 
 
Figure S2 DLS for MINP(1). Distribution of the hydrodynamic diameters of the nanoparticles 
in water as determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) 






Figure S3. DLS for MINP(1).  The correlation curve and the distribution of the molecular 
weight for MINP(1) from the DLS. The PRECISION DECONVOLVE program assumes the 
intensity of scattering is proportional to the mass of the particle squared. If each unit of building 
block for the MINP(1) is assumed to contain one molecule of compound 6  (MW = 465 g/mol), 
1.2 molecules of compound 7 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), 
and 0.8 molecules of compound 8 (MW = 264 g/mol), the molecular weight of MINP(1) 








Figure S4. 1H NMR for MINP(2). 1H NMR spectra of (a) 6 in CDCl3, (b) alkynyl-SCM in 
D2O, and (c) MINP (2) in D2O. 
 
Figure S5. DLS for MINP(2). Distribution of the hydrodynamic diameters of the nanoparticles 
in water as determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) 




                  
 
Figure S6. DLS for MINP(2).  The correlation curve and the distribution of the molecular 
weight for MINP(2) from the DLS. The PRECISION DECONVOLVE program assumes the 
intensity of scattering is proportional to the mass of the particle squared. If each unit of building 
block for the MINP(2) is assumed to contain one molecule of compound 6  (MW = 465 g/mol), 
1.2 molecules of compound 7 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), 
and 0.8 molecules of compound 8 (MW = 264 g/mol), the molecular weight of MINP(2) 











Figure S7. Fluorescence Titration of FM 10 by sodium acetate. (a) Fluorescence emission 
spectra of FM 10  (λex = 280 nm) upon addition of different concentrations of sodium acetate 
in CTAB solution. [CTAB] = 2 mM. [FM 10] = 2.0 μM. (b) Nonlinear least squares fitting of 
the emission intensity of FM 10 at 340 nm to a 1:1 binding isotherm. The data corresponds to 
entry 12 in Table 1.  
 
Figure S8. Fluorescence Titration of FM 10 by sodium butyrate. (a) Fluorescence emission 
spectra of FM 10  (λex = 280 nm) upon addition of different concentrations of sodium butyrate 
in CTAB solution. [CTAB] = 2 mM. [FM 10] = 2.0 μM. (b) Nonlinear least squares fitting of 
the emission intensity of FM 10 at 340 nm to a 1:1 binding isotherm. The data corresponds to 





Figure S9. Fluorescence Titration of FM 10 by sodium octanoate. (a) Fluorescence emission 
spectra of FM 10  (λex = 280 nm) upon addition of different concentrations of sodium octanoate 
in CTAB solution. [CTAB] = 2 mM. [FM 10] = 2.0 μM. (b) Nonlinear least squares fitting of 
the emission intensity of FM 10 at 340 nm to a 1:1 binding isotherm. The data corresponds to 
entry 12 in Table 1.  
 
Figure S10. Flluorescence Titration of FM 11 by sodium acetate. (a) Fluorescence emission 
spectra of FM 11  (λex = 300 nm) upon addition of different concentrations of sodium acetate 
in CTAB solution. [CTAB] = 2 mM. [FM 11] = 2.0 μM. (b) Nonlinear least squares fitting of 
the emission intensity of FM 11 at 370 nm to a 1:1 binding isotherm. The data corresponds  to 





Figure S11. Fluorescence Titration of FM 11 by sodium butyrate. (a) Fluorescence emission 
spectra of FM 11  (λex = 300 nm) upon addition of different concentrations of sodium butyrate 
in CTAB solution. [CTAB] = 2 mM. [FM 11] = 2.0 μM. (b) Nonlinear least squares fitting of 
the emission intensity of FM 11 at 370 nm to a 1:1 binding isotherm. The data corresponds  to 
entry 12 in Table 1.  
 
Figure S12. Fluorescence Titration of FM 11 by sodium octanoate. (a) Fluorescence 
emission spectra of FM 11  (λex = 300 nm) upon addition of different concentrations of sodium 
octanoate in CTAB solution. [CTAB] = 2 mM. [FM 11] = 2.0 μM. (b) Nonlinear least squares 
fitting of the emission intensity of FM 11 at 370 nm to a 1:1 binding isotherm. The data 





Figure S13. Fluorescence Titration of FM 12 by sodium acetate. (a) Fluorescence emission 
spectra of FM 12  (λex = 340 nm) upon addition of different concentrations of sodium acetate 
in CTAB solution. [CTAB] = 2 mM. [FM 12] = 2.0 μM. (b) Nonlinear least squares fitting of 
the emission intensity of FM 12 at 430 nm to a 1:1 binding isotherm. The data corresponds  to 
entry 12 in Table 1.  
 
 
Figure S14. Fluorescence Titration of FM 12 by sodium butyrate. (a) Fluorescence emission 
spectra of FM 12  (λex = 340 nm) upon addition of different concentrations of sodium butyrate 
in CTAB solution. [CTAB] = 2 mM. [FM 12] = 2.0 μM. (b) Nonlinear least squares fitting of 
the emission intensity of FM 12 at 430 nm to a 1:1 binding isotherm. The data corresponds  to 






Figure S15. Fluorescence Titration of FM 12 by sodium octanoate. (a) Fluorescence 
emission spectra of FM 12  (λex = 340 nm) upon addition of different concentrations of sodium 
octanoate in CTAB solution. [CTAB] = 2 mM.  [FM 12] = 2.0 μM. (b) Nonlinear least squares 
fitting of the emission intensity of FM 12 at 430 nm to a 1:1 binding isotherm. The data 
corresponds  to entry 12 in Table 1.  
 
Figure S16. Fluorescence Titration of MINP(1) (1 equiv. FM) by 1. (a) Fluorescence 
emission spectra of MINP(1) (1 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 1 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 





Figure S17. Fluorescence Titration of MINP(1) (1 equiv. FM) by 2. (a) Fluorescence 
emission spectra of MINP(1) (1 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 2 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 
The data corresponds  to entry 2 in Table 2. 
 
Figure S18. Fluorescence Titration of MINP(1) (1 equiv. FM) by 3. (a) Fluorescence 
emission spectra of MINP(1) (1 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 3 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 





Figure S19. Fluorescence Titration of MINP(1) (2 equiv. FM) by 2. (a) Fluorescence 
emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 2 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 
The data corresponds  to entry 5 in Table 2. 
 
Figure S20. Fluorescence Titration of MINP(1) (2 equiv. FM) by 3. (a) Fluorescence 
emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 3 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 





Figure S21. Fluorescence Titration of MINP(1) (2 equiv. FM) by 4. (a) Fluorescence 
emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 4 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 
The data corresponds  to entry 7 in Table 2. 
 
Figure S22. Fluorescence Titration of MINP(1) (2 equiv. FM) by 5. (a) Fluorescence 
emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 5 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 





Figure S23. Fluorescence Titration of MINP(1) (2 equiv. FM) by 6. (a) Fluorescence 
emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 6 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 
The data corresponds  to entry 9 in Table 2. 
 
Figure S24. Fluorescence Titration of MINP(1) (2 equiv. FM) by acetic acid. (a) 
Fluorescence emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of 
different concentrations of acetic acid  in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding 





Figure S25. Fluorescence Titration of MINP(1) (2 equiv. FM) by butyric acid. (a) 
Fluorescence emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of 
different concentrations of butyric acid in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. 
(b) Nonlinear least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 
binding isotherm. The data corresponds  to entry 11 in Table 2. 
 
Figure S26. Fluorescence Titration of MINP(1) (2 equiv. FM) by benzoic acid. (a) 
Fluorescence emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of 
different concentrations of benzoic acid in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. 
(b) Nonlinear least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 





Figure S27. Fluorescence Titration of MINP(1) (2 equiv. FM) by citric acid. (a) 
Fluorescence emission spectra of MINP(1) (2 equiv. FM) (λex = 340 nm) upon addition of 
different concentrations of citric acid in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding 
isotherm. The data corresponds  to entry 13 in Table 2. 
 
Figure S28. Fluorescence Titration of MINP(1) (3 equiv. FM) by 1. (a) Fluorescence 
emission spectra of MINP(1) (3 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 1 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 





Figure S29. Fluorescence Titration of MINP(1) (3 equiv. FM) by 2. (a) Fluorescence 
emission spectra of MINP(1) (3 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 2 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 
The data corresponds  to entry 15 in Table 2. 
 
Figure S30. Fluorescence Titration of MINP(1) (3 equiv. FM) by 3. (a) Fluorescence 
emission spectra of MINP(1) (3 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 3 in 50 mM Tris buffer (pH 7.4). [MINP(1)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(1)  at 420 nm to a 1:1 binding isotherm. 





Figure S31. Fluorescence Titration of MINP(2) (2 equiv. FM) by 1. (a) Fluorescence 
emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 1 in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 binding isotherm. 
The data corresponds  to entry 1 in Table 2. 
 
Figure S32. Fluorescence Titration of MINP(2) (2 equiv. FM) by 2. (a) Fluorescence 
emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 2 in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 binding isotherm. 





Figure S33. Fluorescence Titration of MINP(2) (2 equiv. FM) by 3. (a) Fluorescence 
emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 3 in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 binding isotherm. 
The data corresponds  to entry 3 in Table 2. 
 
Figure S34. Fluorescence Titration of MINP(2) (2 equiv. FM) by 4. (a) Fluorescence 
emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 4 in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 binding isotherm. 





Figure S35. Fluorescence Titration of MINP(2) (2 equiv. FM) by 5. (a) Fluorescence 
emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 5 in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 binding isotherm. 
The data corresponds  to entry 5 in Table 2. 
 
 
Figure S36. Fluorescence Titration of MINP(2) (2 equiv. FM) by 6. (a) Fluorescence 
emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of different 
concentrations of guest 6 in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. (b) Nonlinear 
least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 binding isotherm. 





Figure S37. Fluorescence Titration of MINP(2) (2 equiv. FM) by acetic acid. (a) 
Fluorescence emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of 
different concentrations of acetic acid  in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 binding 
isotherm. The data corresponds  to entry 7 in Table 2. 
 
 
Figure S38. Fluorescence Titration of MINP(2) (2 equiv. FM) by butyric acid. (a) 
Fluorescence emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of 
different concentrations of butyric acid in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. 
(b) Nonlinear least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 





Figure S39. Fluorescence Titration of MINP(2) (2 equiv. FM) by benzoic acid. (a) 
Fluorescence emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of 
different concentrations of benzoic acid in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. 
(b) Nonlinear least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 
binding isotherm. The data corresponds  to entry 9 in Table 2. 
 
 
Figure S40. Fluorescence Titration of MINP(2) (2 equiv. FM) by citric acid. (a) 
Fluorescence emission spectra of MINP(2) (2 equiv. FM) (λex = 340 nm) upon addition of 
different concentrations of citric acid in 50 mM Tris buffer (pH 7.4). [MINP(2)] = 2.0 μM. (b) 
Nonlinear least squares fitting of the emission intensity of MINP(2)  at 420 nm to a 1:1 binding 






Figure S41. Limit of detection. Normalized response of fluorescence signal of MINP(1) in 50 
mM Tris buffer (pH = 7.4, 2 µM) in the presence of increasing amount of 1  (1 µM to 5 µM) 
predissolved in buffer solution. (λex = 370 nm; λem = 420 nm). The detection limit for 1
 was 
calculated to be 144 nM (Detection limit = 3σ/K = 4.89/33.9 × 10-6 M ≈ 144 nM). 
 
 
Figure S42. Limit of detection. Normalized response of fluorescence signal of MINP(2) in 50 
mM Tris buffer (pH = 7.4, 2 µM) in the presence of increasing amount of 2 (1 µM to 5 µM) 
predissolved in buffer solution. (λex = 370 nm; λem = 420 nm). The detection limit for 2
 was 
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CHAPTER 5. SELECTIVE BINDING OF DOPAMINE AND ADRENALINE IN 
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ABSTRACT. Catecholamines (CAs) such as dopamine and epinephrine played important roles 
in biology but their structural similarity makes it challenging to construct synthetic receptors 
with selective binding. A combination of covalent (boronate) and noncovalent (hydrogen-
bonds) in molecularly imprinted cross-linked micelles was effective to distinguish these 
compounds and other related biological analogues. Micromolar binding affinities were 
observed and the binding was reported by fluorescent signals. An extra hydroxyl or methyl on 
the structure was readily detected, making these water-soluble nanoparticle receptors 
potentially useful in biological applications.       
Introduction 
Catecholamines (CAs) such as dopamine (DA, 1), epinephrine (EP, 2), and 
norepinephrine (NE, 3) are neurotransmitters and/or hormones that regulate a plethora 
of biological processes including reward signalling, motor control, sleep, and stress.1-3 
Their biological significance has motivated many researchers to construct synthetic 
receptors, sensors, and fluorescent tracers that help the study of their biological 
activities.4, 5 Receptors and molecular sensors can be built to form reversible covalent 




boronate ester formation, respectively.6-8 Noncovalent interactions may also be used, 
including hydrogen-bonds, ion-pairs, and cation–π interactions, typically using a 
macrocyclic or tweezer framework.9-15     
CAs are metabolized from tyrosine via intermediate 3,4-dihydroxyphenylalanine (i.e., 
L-DOPA, 4). The latter can cross the blood–brain barrier and is used to increase the 
concentration of DA in the brain for patients with DA deficiency (e.g., Parkinson’s 
disease).1-3 Other naturally occurring analogues of CAs include tyrosine (5), 3-
methoxytryamine (6), and tyramine (7). 
 
The structural similarity of CAs, their metabolic precursors, and other biogenic amines make 
it very challenging for a receptor to bind a particular CA selectively. Imine/iminium can be 
formed between an aldehyde and any one of 1–7, although the reaction rates could differ. 
Because boronate ester can form between a boronic acid and 1–4, using both imine and 




binding, a significant challenge comes from the aqueous environment, as water is an excellent 
hydrogen-bond donor and acceptor. With a large penalty paid for desolvation, most 
noncovalently based synthetic receptors either do not function in water or bind the 
compounds weakly.  
 
 
In this work, we report a method to combine specific covalent and noncovalent 
interactions to build selective nanoparticle receptors for CAs in water, using DA and EP 
as examples. The combination not only afforded micromolar binding affinities, but also 
allowed us to distinguish DA and EP, even NE that differs from EP by a single methyl 
group.   
  To build the receptor, we employed micellar imprinting developed by our group, that utilized 
click chemistry-based surface cross-linking and free radical core-cross-linking for the 
templated polymerization (Scheme 1).16 Although the concept of molecular imprinting has been 
known for decades,17, 18 our method differed in several key aspects (Scheme 1). First, the key 
 




imprinting step takes place in the surface-cross-linked micelle, when divinylbenzene (DVB) 
and the methacrylate of 8 undergo polymerization/cross-linking induced by 2,2-dimethoxy-2-
phenylacetophenone (DMPA) under UV irradiation. It has been shown that the nano-
confinement is key to the exceptional imprinting effect observed,19 frequently with the 
imprinting factor exceeding 100.20, 21 Second, the number of binding sites per nanoparticle can 
be simply controlled by the surfactant/template ratio, given that the cross-linked micelle 
contains approximately 50 surfactants.16 Third, being cationically charged and decorated with 
a layer of sugar-derived surface ligand (10), the cross-linked micelles are soluble in water and 
selected organic solvents such as DMF, unlike most molecular imprinted polymers reported in 
the literature.17, 18 Fourth, the resulting molecularly imprinted nanoparticles (MINPs) are ~5 nm 
in diameter according to dynamic light scattering (DLS) and transmission electron microscopy 
(TEM).16, 20 The exceedingly high surface area of MINP and the location of the template near 
the surfactant/water interface—resulted from polar groups represented by the purpose sphere 
in Scheme 1—make the imprinted sites readily accessible. Lastly, covalent groups can be 
introduced in the imprinted site and modified in high yields through standard chemical 
reactions such as amidation and imine formation, due to the solubility of MINP and 
accessibility of the imprinted sites.22, 23 
Preparation and characterization of MINPs are reported in the Supporting Information 
and followed previous procedures.16 To make the MINP recognize CAs, we included 
two functional monomers (FMs) 11 and 12 in the formulation. Compound 11 was 
prepared by a six-step reaction from anthracene. It has several important features: a 
boronic acid with the ortho amino group to bind catechol via boronate formation, a 





to report the binding, and the amino group. FM 12 was first reported by us and was 
shown to be highly effective at binding amino/ammonium side chain of lysine in a 
micellar environment through hydrogen bonds.20  Even though hydrogen-bonds are 
weak in water, they are known to be strengthened inside micelles24, 25 and at the 
surfactant/water interface.26 
Prior to the experiments, our postulation was that DA and EP differ in two aspects. 
EP has an extra hydroxyl next to the amino group and its amino group further 
functionalized with a methyl. Since 12 worked well for the amino side chain of lysine, 
it is expected to form a three-component complex (A) with DA and 11 (Fig. 1). The 
extra methyl of EP, on the other hand, reduces the number of potential hydrogen bonds 
 
Figure 1. Structures of FM 11 and 12, as well as the proposed complexes formed by DA 




to be formed with 12. Meanwhile, its extra β-hydroxyl makes it possible for EP to form 
a 1:2 complex (B) with FM 11.    
 Our Binding data seems to support the above pictures. As shown in Table 1, we first 
prepared MINP(DA), with DA as the template and different ratios of FM/T for 11 and 
12. The binding constants were determined by fluorescence titrations (Figures S7–S32). 
Table 1. Binding constants of MINPs prepared for DA and EP.a 
Entry Template FM 11 FM 12 Guest  Ka (× 10
4 M -1) CRRb 
1 DA 2 equiv 0 equiv DA  1.9 ± 0.5 1 
2 DA 2 equiv 0 equiv EP  0.93 ± 0.06 0.49 
3 DA 1 equiv 1 equiv DA  3.8 ± 0.5 1 
4 DA 1 equiv 1 equiv EP  0.35 ± 0.14 0.09 
5 DA 2 equiv 1 equiv DA  3.1 ± 0.6 1 
6 DA 2 equiv 1 equiv EP  0.42 ± 0.13 0.14 
7 EP 2 equiv 0 equiv DA  0.51 ± 0.04 0.12 
8 EP 2 equiv 0 equiv EP  4.1 ± 0.25 1 
9 EP 1 equiv 1 equiv DA  0.61 ± 0.11 0.81 
10 EP 1 equiv 1 equiv EP  0.75 ± 0.24 1 
11 EP 2 equiv 1 equiv DA  1.0 ± 0.31 0.29 
12 EP 2 equiv 1 equiv EP  3.5 ± 0.51 1 
a Binding constants were obtained from fluorescence titrations performed in duplicates in in 10 
mM Tris buffer (pH = 9.0). b CRR is the cross-reactivity ratio, defined as the binding constant of  




The amount of 11 was varied from 1 to 2 equivalents to the template, and the amount of 
12 from 1 to 1 equivalent. As more FM 11 was used, the binding of DA by MINP(DA) 
first increased from 1.9 to 3.8 × 104 M -1 and then plateaued (within the experimental 
error) to 3.1 × 104 M -1 (entries 1, 3, and 5). Meanwhile, the binding for EP stayed 
relatively weak and reached the minimum at 1:1 11/12 (entry 4). As a result, the strongest 
and most selective binding occurred at this ratio, as we had hypothesized. The selectivity 
is reflected in the cross-reactivity ratio (CRR), defined as the binding constant of a guest 
relative to that of the template for a particular MINP. 
Table 2. Binding constants of MINP(DA).a 
Entr
y 




1 1 (DA) 1 (DA) 3.8 ± 0.5  6.25 1 
2 1 (DA) 2 (EP) 0.35 ± 0.14  4.83 0.09 
3 1 (DA) 3 (NE) 0.72 ± 0.24  5.26 0.19 
4 1 (DA) 4 0.12 ± 0.04  4.20 0.03 
5 1 (DA) 5 0.08 ± 0.02  3.96 0.02 
6 1 (DA) 6 0.05 ± 0.01  3.68 0.01 
7 1 (DA) 7 0.20 ± 0.06  4.50 0.05 
a The MINP was prepared at DA/11/12 = 1:1:1. Binding constants were obtained from fluorescence 
titrations performed in duplicates in in 10 mM Tris buffer (pH = 9.0). b CRR is the cross-reactivity 





 When the same experiments were done with MINP(EP), the optimal ratio was found 
2:0 11/12 (entries 7–8), where the binding for the template was the strongest and for the 
analogue was the weakest. 
Table 2 shows the binding of MINP(DA) for guests 1–7, with the MINP prepared at the 
optimal ratio of DA/11/12 = 1:1:1. Consistent with successful molecular imprinting, the 
strongest binding was observed for the template (DA). The binding constant (3.8 × 104 
M -1) in the aqueous buffer (10 mM Tris) was much larger than what have been reported 
for previous receptors. The number corresponds to a binding free energy (-ΔG) of 6.25 
kcal/mol, which is substantial for a small water-soluble guest. 
Table 3. Binding constants of MINP(EP).a 




1 2 (EP) 1 (DA) 0.51 ± 0.04 5.06 0.12 
2 2 (EP) 2 (EP) 4.1 ± 0.25 6.29 1.00 
3 2 (EP) 3 (NE) 1.9 ± 0.25 5.84 0.46 
4 2 (EP) 4 0.07 ± 0.02 3.88 0.02 
5 2 (EP) 5 0.11 ± 0.01 4.15 0.03 
6 2 (EP) 6 0.03 ± 0.01 3.38 0.01 
7 2 (EP) 7 0.02  ± 0.01 3.14 0.005 
a The MINP was prepared at DA/11/12 = 1:2:0. Binding constants were obtained from fluorescence 
titrations performed in duplicates in in 10 mM Tris buffer (pH = 9.0). b CRR is the cross-reactivity ratio, 





 Among the analogues, the one that showed the highest cross-reactivity was actually 
norepinephrine (NE, 3), followed by epinephrine (EP, 2). Their binding constants 
differed by a factor of 2. This trend is extremely telling, with regard to our binding model 
(Fig. 1). NE only differed from DA by an extra hydroxyl. Everything else was exactly 
the same as the template. Thus, it can engage the same covalent and noncovalent binding 
interactions as the template (DA) with MINP(DA). In this sense, the 5-fold difference 
in binding constant and nearly 1 kcal/mol difference in binding free energy were quite 

























Figure 2. Change of intensity of MINP(DA) and NINP caused by 1–7 in 10 mM Tris buffer (pH 
= 9.0). [MINP] = 0.5 µM. [Guest] = 10 µM. λex = 350 nm. The NINP was prepared with the same 




The extra methyl in EP (2) cost a further reduction of binding energy of ΔΔG = 0.43 
kcal/mol with MINP(DA). The result is reasonable because the methylamino group 
would reduce the number of hydrogen bonds formed with the azacrown ring of FM 12 
and introduce unwanted steric interactions in the binding. Note that the FM will turn into 
binding group inside the imprinted binding pocket.  
Encouragingly, everything else including the CA precursors—i.e., L-DOPA (4) and 
tyrosine (5)—bound very weakly. Structure-wise, an extra carboxylic acid (in 4) was 
much less tolerated than an extra hydroxyl (in 3). The importance of boronate formation 
was clear, as 6 and 7, which were unable to form the boronate ester, showed much 




























Figure 3. Change of intensity of MINP(EP) and NINP caused by 1–7 in 10 mM Tris buffer 
(pH = 9.0). [MINP] = 0.5 µM. [Guest] = 10 µM. λex = 350 nm. The NINP was prepared with 




 MINP(EP) showed very similar trends (Table 3), displaying the strongest binding for 
its own template. Notably, the most interfering analogue was norepinephrine (NE, 3), 
with a CRR of 0.46 (entry 3). Notably, the difference in the binding free energy (ΔΔG) 
was 0.45 kcal/mol, nearly identical to that observed  for the two molecules when 
MINP(DA) was used as the receptor (ΔΔG = 0.43). It is possible that the 
“reproducibility” was simply coincidental. Otherwise, since two different binding 
interactions were used in MINP(DA) and MINP(EP) for the amino group, the identical 
ΔΔG = 0.43 could suggest that the methyl effect had a common origin (e.g., steric or 
hydrophobic in nature). 
Since the binding pocket has a fluorescent group (i.e., anthracene) nearby, it is possible 
to use the MINPs as fluorescent sensors for these compounds Fig. 2 shows the change 
of emission intensity of 0.5 µM MINP(DA) upon the addition of 10 µM 1–7. As 
expected, the targeted analyte (DA) gave the strongest quenching. As a comparison, we 
performed the same experiments with NINP, prepared with the same ratio of 11/12 = 
1:1:1, without the template. As shown by the red columns, the nonimprinted micelles 
showed no noticeable selectivity.     
 We then added 1–7 to MINP(EP). Consistent with our binding data (Table 2), the 
fluorescently functionalized cross-linked micelle was able to sense its own template (EP, 
2) and the strongest interfering analyte was norepinephrine (NE, 3). Selectivity, thus, 
could be predicted by the binding affinities. 
 In summary, we have used a combination of covalent and noncovalent binding groups 
to differentiate closely related biological guests in aqueous solution (CAs and their 




hydroxyl or methyl, and transduced the binding into an easy-to-read fluorescent signal. 
MINPs can be prepared in less than two days once the FMs, cross-linkable surfactant, 
and cross-linkers are available. This work shows they have many of the “ideal” features 
illustrated in the  Zimmerman review,27 including “imprinting in water, simple 
preparation and purification, spectroscopic detection of binding, homogenous binding 
sites, and good processability”. With easily modified surface and interior,  as well as 
guest-sensitive fluorescent properties, these MINP have potential for many applications.    
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General Method 
 
Routine 1H and 13C NMR spectra were recorded on a Bruker DRX-400, on a Bruker AV II 600 
or on a Varian VXR-400 spectrometer.  ESI-MS mass was recorded on Shimadzu LCMS-2010 
mass spectrometer.  Dynamic light scattering (DLS) data were recorded at 25 °C using PDDLS/ 
CoolBatch 90T with PD2000DLS instrument.  Isothermal titration calorimetry (ITC) was 
performed using a MicroCal VP-ITC Microcalorimeter with Origin 7 software and 






Scheme 1S: syntheses of fluorescent functional monomer 11. 
 
Syntheses 
Compound 14-16 were synthesized following reported procedures. 1-3 
Compound 18A mixture of compound 16 (364 mg, 1 mmol), 17 (240 mg, 1.2 mmol) and 
potassium carbonate (152 mg, 1.2 mmol) in dry acetonitrile (50 mL) was heated to reflux under 
an argon atmosphere for 20 h. After the solid was filtered off, the filtrate was concentrated by 
rotary evaporation. The residual was then dissolved in dichloromethane, then washed three 
times by water. The organic layer was collected and dried by anhydrous sodium sulfate, and 
the solvent was then removed by rotaevaporation. The obtained crude product was further 
purified by column chromatography (CH2Cl2/MeOH, 20:1) to give a yellow powder (275 mg, 
55%). 1H NMR (400 MHz, Chloroform-d) δ 8.42 (s, 2H), 8.11 (m, 3H), 7.57 – 7.20 (m, 
7H), 5.51 (s, 2H), 4.48 (s, 2H), 4.06 (s, 2H), 2.47 (s, 3H), 2.24 (s, 3H), 1.57 (s, 9H). 13C 




127.88, 126.11, 125.96, 125.53, 125.49, 124.62, 83.24, 65.70, 58.38, 50.51, 42.15, 
20.26, 17.42. HRMS (ESI/QTOF) m/z: [M + H]+ Calcd for C30H36BN2O4 499.2768; 
Found 499.2778 
 
Compound 10. A solution of compound 18 (499 mg, 1 mmol) in 5 mL of anhydrous 
dichloromethane was added slowly to a 10 mL mixture of 50:50 dichloromethane and 
trifluoroacetic acid. After stirred at room temperature for 1 h, the mixture was concentrated by 
rotary evaporation. The residual was dissolved in anhydrous dichloromethane (10 mL), 
followed by the addition of triethylamine (0.3 mL) and methacryloyl chloride (0.2 mL, 2 mmol). 
The reaction mixture was stirred at room temperature for 12 h. The reaction solution was then 
extracted three times by water. The organic layer was collected and dried by anhydrous sodium 
sulfate, and the solvent was then removed by rotary evaporation. The obtained crude product 
was further purified by column chromatography over silica gel using 10:1 
dichloromethane/methanol as the eluent to give a yellow powder (284 mg, 61%). 1H NMR (600 
MHz, CDCl3) δ 8.36 (d, J = 8.4 Hz, 2H), 8.23–8.10 (m, 3H), 7.55–7.44 (m, 7H), 5.71 (d, J = 
4.9 Hz, 2H), 5.19 (s, 1H), 5.04 (s, 1H), 4.52 (s, 2H), 4.00 (s, 2H), 2.60 (s, 3H), 2.25 (s, 3H), 
2.01 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 172.3, 141.3, 141.2, 140.9, 136.0, 131.1, 130.9, 
130.0, 127.9, 126.1, 126.0, 125.5, 124.7, 115.5, 65.7, 58.4, 50.5, 42.2, 20.3, 17.4. HRMS 














Figure S2. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP(DA) 





Figure S3. The correlation curve and the distribution of the molecular weight for MINP(DA) 
from the DLS. The PRECISION DECONVOLVE program assumes the intensity of scattering 
is proportional to the mass of the particle squared. If each unit of building block for the 
MINP(DA) is assumed to contain one molecule of compound 8 (MW = 465 g/mol), 1.2 
molecules of compound 9 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), and 
0.8 molecules of compound 10 (MW = 264 g/mol), the molecular weight of MINP(DA) 













Figure S5. Distribution of the hydrodynamic diameters of the nanoparticles in water as 
determined by DLS for (a) alkynyl-SCM, (b) surface-functionalized SCM, and (c) MINP(EP) 






Figure S6. The correlation curve and the distribution of the molecular weight for MINP(EP) 
from the DLS. The PRECISION DECONVOLVE program assumes the intensity of scattering 
is proportional to the mass of the particle squared. If each unit of building block for the 
MINP(EP) is assumed to contain one molecule of compound 8 (MW = 465 g/mol), 1.2 
molecules of compound 9 (MW = 172 g/mol), one molecule of DVB (MW = 130 g/mol), and 
0.8 molecules of compound 10 (MW = 264 g/mol), the molecular weight of MINP1(8) 














Figure S7. (a) Fluorescence emission spectra of MINP(DA) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest DA in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 
of MINP(DA) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 1 in Table 1. 
 
 
Figure S8. (a) Fluorescence emission spectra of MINP(DA) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest EP in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 





Figure S9. (a) Fluorescence emission spectra of MINP(DA) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest DA in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 
of MINP(DA) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 3 in Table 1 
and entry 1 in Table 2. 
 
Figure S10. (a) Fluorescence emission spectra of MINP(DA) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest EP in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 
of MINP(DA) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 4 in Table 1 






Figure S11. (a) Fluorescence emission spectra of MINP(DA) (2 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest DA in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 
of MINP(DA) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 5 in Table 1. 
 
Figure S12. (a) Fluorescence emission spectra of MINP(DA) (2 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest EP in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 





Figure S13. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest DA in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 
MINP(EP) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 7 in Table 1 and 
entry 1 in Table 3. 
 
 
Figure S14. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest EP in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 
MINP(EP) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 8 in Table 1 and 





Figure S15. (a) Fluorescence emission spectra of MINP(EP) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest DA in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 
MINP(EP) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 9 in Table 1. 
 
Figure S16. (a) Fluorescence emission spectra of MINP(EP) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest EP in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 






Figure S17. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest DA in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 
MINP(EP) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 11 in Table 1. 
 
Figure S18. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest EP in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 







Figure S19. (a) Fluorescence emission spectra of MINP(DA) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest NE in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 
of MINP(DA) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 3 in Table 2. 
 
Figure S20. (a) Fluorescence emission spectra of MINP(DA) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest 4 in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 





Figure S21. (a) Fluorescence emission spectra of MINP(DA) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest 5 in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 
of MINP(DA) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 5 in Table 2. 
 
Figure S22. (a) Fluorescence emission spectra of MINP(DA) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest 6 in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 






Figure S23. (a) Fluorescence emission spectra of MINP(DA) (1 equiv. FM 11 & 1 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest 7 in 50 mM Tris buffer 
(pH 7.4). [MINP(DA)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity 







Figure S24. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest NE in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 
MINP(EP) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 3 in Table 3. 
 
Figure S25. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest 4 in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 





Figure S26. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest 5 in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 
MINP(EP) at 430 nm to a 1:1 binding isotherm. The data corresponds to entry 5 in Table 3. 
 
Figure S27. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest 6 in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 





Figure S28. (a) Fluorescence emission spectra of MINP(EP) (2 equiv. FM 11 & 0 equiv. FM 
12) (λex = 370 nm) upon addition of different concentrations of guest 7 in 50 mM Tris buffer 
(pH 7.4). [MINP(EP)] = 2.0 μM. (b) Nonlinear least squares fitting of the emission intensity of 
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CHAPTER 6. GENERAL CONCLUSIONS  
  
Although molecule recognition in water is challenging for many artificial receptors, 
this work demonstrates that molecularly imprinted nanoparticles (MINPs) could be used as 
receptors or sensors for a variety of bioactive molecules including alkaloids, nonsteroidal anti-
inflammatory drug (NSAIDs), folic acid, and catecholamines in water. The preparation of 
MINP is extremely easy and convenient, complete in 2-3 days from readily available starting 
materials without harsh reaction conditions. Although the binding affinity might still be weak 
compared to those of natural antibodies, the rigid polymer matrix would enable MINP to work 
under adverse temperature and pH conditions, in which a protein easily denature. In addition, 
in comparison to other reported synthetic receptors, MINPs generally function much better in 
water with outstanding binding affinities and good selectivity toward similar structures. 
MINPs also represent a large improvement from traditional molecularly imprinted polymers, 
with their good water solubility, small size, and controllable numbers of the binding site. With 
a judicious selection of the cross-linkable surfactant and functional monomers, MINPs can be 
prepared for many other target molecules beyond bioactive drugs. Finally, installation of 
fluorescent functional monomers near the binding site converts MINP receptors into sensors, 
which can be very useful in biomedical research and diagnosis.  
 
  
 
 
